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Part I 
Trafficking of Lyn through the Golgi caveolin involves the 
charged residues on αE and αI helices in the kinase domain 
 
Abstract 
Src-family kinases, known to participate in signaling pathways of a variety of surface receptors, are 
localized to the cytoplasmic side of the plasma membrane through the lipid modification. We show here 
that Lyn, a member of the Src-family kinases, is biosynthetically transported to the plasma membrane via 
the Golgi pool of cavelin along the secretory pathway. The trafficking of Lyn from the Golgi apparatus to 
the plasma membrane is inhibited by deletion of the kinase domain or Csk-induced “closed conformation” 
but not by the kinase inactivation. Four negative charged residues (Asp 346 and Glu353 on αE helix, and 
Asp498 and Asp499 on αI helix) present in the C-lobe of the kinase domain, which can be exposed to the 
molecular surface through an “open conformation”, are identified as being involved in export of Lyn from 
the Golgi apparatus toward the plasma membrane but not targeting to the Golgi apparatus. Thus, the 
kinase domain of Lyn plays a role in Lyn trafficking besides catalysis of  substrate phospholylation. 
 
 
Introduction 
   Src-family protein tyrosine kinases, which belong to a family of nonreceptor-type tyrosine kinases, comprise 
proto-oncogene products and structurally related proteins, and include at least eight members with significant 
amino acid sequence homology (c-Src, Lyn, c-Yes, Fyn, c-Fgr, Hck, Lck, and Blk). Src-family kinases are 
known to play crucial roles in regulating proliferation and differentiation, especially cell growth control, gene 
expression, metabolism, and cytoskeletal architecture (1). Multiple combinations of Src-family kinase members 
are expressed in many cell types and are involved in individual and overlapping signaling pathways (2). 
   Src-family kinases are composed of: (a) an NH2-termianl Src homology (SH) 4 domain that contains lipid 
modification sites for myristoylation mostly together with palmitoylation; (b) poorly conserved “unique” domain, 
which is hyper variable among Src-family kinases; (c) an SH3 domain, which can bind to specific proline-rich 
sequences; (d) an SH2 domain, which bind to specific sites of tyrosine phosphorylation; (e) an SH1 tyrosine 
kinase catalytic domain; and (f) a COOH-terminal negative regulatory tail for autoinhibition of kinase activity 
(3). The tyrosine kinase activity of Src-family kinases is repressed through creating a distinctive “closed 
conformation” due to the intra-molecular binding of the SH2 domain to the tyrosine phosphorelated tail 
catalyzed by the Csk-family and of the SH3 domain to the SH2-kinase linker (4, 5). The absence of this 
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COOH-terminal tyrosine residue, as found in the viral oncogenic forms, leads to cell transformation due to 
constitutive kinase-activation by derepression (3, 6). 
   Src-family kinases, classified as cytosolic enzymes, are localized at the cytoplasmic face of the plasma 
membrane through posttranslational myristoylation (7), but an appreciable fraction is found at the perinuclear 
region (8, 9), which may correspond to associate with late endosomes (10), and at other locations including 
synaptic vesicles (11) and secretory granules/phagosomes (12). Previous studies on c-Src, Lck, Fyn, and Hck (9, 
10, 13-18) elaborately explored the localizations of the Src-family kinases by immunostaining or 
pulse-radiolabeling and –chase experiments coupled with subcellular fractionation. Although distinctive 
localizations of individual members of Src-family kinases have been implicated in their specific functions, the 
mechanism of their diverse intracellular localizations has thus far not been fully provided. Therefore, we wished 
to examine how Src-family kinases can localize and to determine which elements can function for the 
localization. 
   Here, we chose Lyn that belongs to a member of the Src-family kinases because Lyn is widely expressed in a 
variety of organs, tissues, and cell types such as epidermoid, hematopoietic, and neuronal cell, and plays an 
important role in signal transduction at the cytoplasmic side of the plasma membrane (19-24). To explore the 
basis that determines intracellular localization of Lyn, we took an approach for spatial and temporal detection of 
Lyn and its mutants, using an inducible or transient expression of Lyn or Lyn fused with the GFP visualized by 
confocal microscopy. 
   Here, we show that Lyn is mainly localized to both the plasma membrane and a fraction of caveolin, a maker 
for a class of endosomes, which is present at the Golgi apparatus. After biosynthesis, Lyn is rapidly associated 
with the Golgi pool of caveolin, and then transported to the plasma membrane. The trafficking of Lyn from the 
Golgi apparatus to the plasma membrane requires the kinase domain per se but not the kinase activity. We further 
identify four negative-charged amino acid residues, which are conserved among Src-family kinases and aligned 
on one side of the C-lobe of the kinase domain, responsible for the trafficking of Lyn to the plasma membrane. 
Our findings demonstrate the significance of the C-lobe through an open conformation for export of Lyn from 
the Golgi apparatus to the plasma membrane. 
 
Results 
Predominant localization of Lyn to the perinuclear region caused by kinase-domain deletion. 
   To explore an element that can affect subcellular localization of Lyn, we examined the localization of a 
kinase-active Lyn mutant (Lyn-HA) and a kinase-domain deleted Lyn mutant (LynΔK-HA; Fig. 1A) by 
generating HeLa cell clones that express Lyn-HA or LynΔK-HA in an inducible manner. When induced by 
addition of doxycycline, a tetracycline derivative, Lyn-HA was detected at the plasma membrane and the 
perinuclear region (Fig. 1B), whereas LynΔK-HA was predominantly seen in the perinuclear region (Fig. 1C). 
Until 3 h after induction, protein expression could not be detected by our immunostaining. In the course of 
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induction, a majority of Lyn-HA was initially observed in the perinuclear region and subsequently detected at the 
plasma membrane (Fig. 1D), whereas LynΔK-HA was almost restricted to the perinuclear region during the 
observation period (Fig. 1E). These results suggest that upon expression Lyn may initially become accumulated 
at the perinuclear region and that its subsequent appearance at the plasma membrane may involve the kinase 
domain. 
   Furthermore, transient expression of Lyn and its mutants in COS-1 cells enabled us to classify their features 
of localization as three patterns (PeriN, PeriN = PM, and PM) on the basis of rations in amounts of expressed 
proteins between the perinuclear region (PeriN) and the plasma membrane (PM) (Fig. 1F; see Materials and 
Methods). Fig. 1G shows that (a) Lyn, (b) Lyn-HA, and (c) LynΔK-HA irrespective of the difference in structure 
were predominantly observed in the perinuclear region during the earlier phase of expression. In the latter phase, 
a majority of Lyn and Lyn-HA were observed at the plasma membrane, whereas an appreciable fraction of 
LynΔK-HA still restricted in the perinuclear region. These results are consistent with the results of HeLa cells 
shown in Fig. 1 (D and E). 
 
Spatial association of Lyn with caveolin at the Golgi apparatus 
   To characterize the perinuclear region, cross sections of the confocal images were acquired in the z axis. Fig. 
1A shows that a large fraction of perinuclear Lyn was colocalized with β–1, 4-galactosyltransferase (GalT), a 
trans-Golgi resident protein. Notably, Lyn was precisely colocalized with caveolin in the perinuclear region 
whereas Lyn and caveolin were poorly colocalized at the plasma membrane (Fig. 2B). These results indicate that 
Lyn is colocalized with a pool of caveolin at the Golgi apparatus. 
   The recent data suggest that the presence of the Golgi pool of caveolin is dependent on new protein synthesis 
and not on exchange with caveolin at the plasma membrane or in enodosomes (25). To examine the relationship 
between Lyn and caveolin at the Golgi apparatus, cells were treated with cycloheximide (CHX), an inhibitor or 
protein synthesis. As shown in Fig. 2 (C and D), treatment of Lyn-expressing cells with CHX emptied caveolin 
from the Golgi apparatus, which was accompanied by elimination of perinuclear Lyn. However, CHX treatment 
did not disturb localization of Lyn to the plasma membrane. Given that Lyn and caveolin were poorly 
colocalized at the plasma membrane (Fig. 2B), these results implicate that Lyn may be temporally associated 
with caveolin at the Golgi apparatus before its reach to the plasma membrane. 
   Next, to examine whether localization of endogenous Lyn was similar to that of overexpressed Lyn, we 
immunostained HeLa and COS-1 cells with anti-Lyn. As shown in Fig. 2E (top), endogenous Lyn was 
colocalized with GalT in HeLa cells as observed in Lyn-transfected COS-1 cells (Fig. 2A). Although endogenous 
Lyn was detected in COS-1 cells by Western blotting, it could not be visualized by our immunostaining probably 
due to lower expression (unpublished data). We then tested the localization of endogenous Lyn for sensitivity to 
brefeldin A (BFA), because BFA is known to cause disassembly and redistribution of the Golgi apparatus into the 
ER (26). Fig. 2E (bottom) shows that endogenous Lyn present at the Golgi apparatus was dispersed by BFA 
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treatment in accordance with redistribution of GalT into the ER. The dispersal of Lyn from the Golgi apparatus 
was also observed in Lyn-HA-expressing COS-1 cells (Fig. 7A). These results indicate suggest that both 
endogenous Lyn and overexpressed Lyn are similarly localized to the Golgi apparatus in a BFA-sensitive 
manner. 
 
Trafficking of newly synthesized Lyn through the Golgi apparatus toward the plasma membrane 
   The Lyn-GFP fusion protein contains the almost entire structure of Lyn-HA, including the NH2-terminal lipid 
attachment sites for myristoylation and palmitoylation, and is likely to preserve all functions of Lyn-HA. Indeed, 
the localization of Lyn-GFP visualized by fluorescence of GFP or anti-Lyn immunostaining was consistent with 
that of Lyn-HA detected with anti-Lyn or anti-HA immunostaining (unpublished data). Using FRAP techniques, 
the trafficking of Lyn-GFP after biosynthesis was monitored in living COS-1 cells transfected with Lyn-GFP. 
When whole cell area was photobleached, rapid recovery of Lyn-GFP fluorescence was observed in both the 
perinuclear region (Fig. 3A, circled area) and the plasma membrane (Fig. 3A, boxed area). In particular, the 
recovery rate of Lyn-GFP fluorescence in the perinuclear region was much higher than that at the plasma 
membrane. Upon expression of adequate levels of Lyn-GFP mRNA, FRAP can ensure rapid detection of 
trafficking of Lyn-GFP just after biosynthesis. The apparently slow kinetics (Fig. 1, D-G) could be explained by 
our inability to immunodetect Lyn proteins at low levels of Lyn mRNA during the early phase of induction. 
   When perinuclear Lyn-GFP was selectively photobleached, rapid recovery of Lyn-GFP fluorescence was 
observed in the perinuclear region (Fig. 3B). In sharp contrast, treatment with CHX completely blocked recovery 
of perinuclear Lyn-GFP after selective photobleaching of the perinuclear region. These results indicate that the 
appearance of Lyn at the Golgi apparatus requires protein biosynthesis, suggesting that Lyn barely recycles from 
the plasma membrane to the Golgi apparatus. 
   To test whether vesicular transport was required for localization of Lyn-GFP to the plasma membrane, we 
used N-ethyl-maleimide (NEM), a reagent known to block a wide range of vesicular fusion events (27). 
Fluorescence recovery of Lyn-GFP was monitored in the absence or presence of NEM after whole cell area 
excluding the perinuclear region was photobleached. As shown in Fig. 3C, treatment of Lyn-GFP-expressing 
COS-1 cells with NEM strongly blocked fluorescence recovery of Lyn-GFP at the plasma membrane (boxed 
area). Photobleaching of whole cell area in the presence of NEM ensured fluorescence recovery of Lyn-GFP at 
the perinuclear region (Fig. 3D). These results suggest that newly synthesized Lyn is initially transported to the 
Golgi apparatus by nonvesicular transport but not targeted directly to the plasma membrane, and that the 
trafficking of Lyn from the Golgi apparatus en route to the plasma membrane is mediated by exocytic vesicular 
transport. 
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Requirement of the kinase domain but not kinase activity for Lyn trafficking to the plasma 
membrane 
   The catalytic activity of Src-family tyrosine kinases is inhibited by creating a “closed conformation” through 
Csk tyrosine kinase-mediated phosphorylation of the COOH-terminal tyrosine residues (3). To examine whether 
kinase activity was required for localization of Lyn to the plasma membrane, we cotransfected COS-1 cells with 
Lyn and Csk. Their concomitant expression was found to increase the localization of Lyn to the Golgi apparatus 
and decrease that to the plasma membrane (Fig. 4A and B). In vitro kinase assays verified the inhibition of Lyn 
kinse activity by coexpressed Csk (Fig. 4C). Localization of Lyn-HA, which is devoid of the COOH-terminal 
tyrosine residues of Lyn, to the plasma membrane was unaffected by Csk coexpression (Fig. 4A), indicating the 
inhibition through Csk-mediated phosphorylation of the COOH-terminal tyrosine residue of Lyn. 
   We then created a kinase-inactive mutant, Lyn(K275A)-HA by replacing Lyn-275 to alanine in the 
ATP-binding site. Fig. 4D confirmed that Lyn(K275A)-HA was deficient in tyrosine kinase activities for 
phosphorylation of celluar proteins and autophosphorylation. To our surprise, localization of Lyn(K275A)-HA 
was essentially similar to that of Lyn-HA (Fig. 4A). Furthermore, treatment of PP2, a Src inhibitor, that accesses 
a hydrophobic pocket structure near the ATP-binding cleft of Src-family tyrosine kinases (28), was unable to 
inhibit localization of Lyn to the plasma membrane (Fig. 4A), although the kinase activity of Lyn was greatly 
reduced (not depicted). These findings demonstrate that the kinase domain per se but not the kinase activity 
plays an important role in localization of Lyn to the plasma membrane. 
 
The C-lobe responsible for Lyn trafficking to the plasma membrane 
   To identify the structure or an element in the kinase domain responsible for the localization, we constructed 
various deletion mutants of Lyn-HA and analyzed the expressed protein in COS-1 cells by Western blotting. As 
shown in Fig. 5A, each of these mutant proteins was detected at the expected size and the expression level of 
each protein was comparable. Fig. 5B provide evidence that the localization of Lyn to the plasma membrane 
involves the structure encompassing amino acids 236-506 in Lyn-HA, suggesting that the importance of the 
NH2- and COOH-terminal lobes of the kinase domain. However, the crystal structures of Hck and c-Src indicate 
that the αA helix in the SH2 domain electrostatically interacts with the αE and αI helices in the C-lobe of kinase 
domain (Fig. 6A; 4, 5) If electrostatic interactions between the SH2 domain and the C-lobe are extremely 
strengthened by deletion of both the SH2 linker and the N-lobe that might function as a spring hinge, one would 
predict that the SH2 domain tightly masks an element on the C-lobe responsible for plasma membrane 
localization. Therefore, we created the Lyn mutant (Δ121-324) by deletion of SH2-domain, the SH2 linker and 
the N-lobe (Fig. 5A). Fig. 5C reveals that, like Lyn-HA, the Lyn mutant (Δ 121-324) was initially accumulated at 
the Golgi apparatus and was then able to efficiently localized to the plasma membrane. This indicates that the 
N-lobe is dispensable for the plasma membrane localization. It should be noted that the αE and αI helices are 
positioned side by side on the same surface of the C-lobe (Fig. 6A). Therefore, it is likely that the αE and αI 
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helices present on the C-lobe are candidate structures that could be only exposed to the molecular surface of Lyn 
in an “open conformation” but be masked in a “closed conformation” induced by Csk phosphorylation. 
 
Identification of four negative-charged residues on the C-lobe 
   The overall organization of c-Src and Hck (Fig. 6A) and the interactions of the SH2 and catalytic domains 
(Fig. 6B) were provided (4, 5, 29). Structure-based amino acid sequence alignment indicates that three positive 
-harged residues on the αA helix in the SH2 domain and four negative-charged residues aligned on one side of 
the αE and αI helices in the C-lobe are conserved among the members of the Src-family (Fig. 6C), predicting 
that Lyn, similar to c-Src and Hck, is structurally organized with the αA helix (Arg-136, Lys-137, and Arg-141) 
in the SH2 domain, and with the αE (Asp-346, and Glu-353) and αI (Asp-498 and Asp-499) helices in the 
C-lobe). 
   We created three alanine-substitution mutants of the C-lobe, DE-mt, DD-mt, and Tetra-mt, as depicted in Fig. 
6D. The levels of protein expression and kinase activity for autophosphorylation were comparable in COS-1 
cells transfected with Lyn-HA or each Lyn mutant (Fig. 6E). Intriguingly, mutations of the negative-charged 
residues were found to inhibit the localization of Lyn-HA to the plasma membrane in both HeLa and COS-1 cells 
(Fig. 6F). Among DE-mt, DD-mt, and Tetra-mt, Tetra-mt exhibited the maximum inhibition of plasma 
membrane localization, which closely corresponded to the data of Lyn(Δ 236-298) as a control (Fig. 5B compare 
Δ 236-298 with Δ K-HA). These results suggest that the four negative-charged residues in the C-lobe play a role 
in the trafficking of Lyn-HA to the plasma membrane. 
 
Role of four negative-charged residues in the C-lobe in the trafficking of Lyn 
   Next, we examined whether localization of Lyn-HA and Tetra-mt was affected by treatment with BFA. Fig. 
7B shows that Tetra-mt, like Lyn-HA (Fig. 7A, top), was colocalized with GalT in the absence of BFA. The 
levels of Tetra mt that were accumulated at the Golgi apparatus appeared to be slightly higher that those of 
Lyn-HA as judged by fluorescence intensities (Fig. 7, compare B with A). Upon treatment with BFA, Tetra-mt 
and Lyn-HA were both dispersed from the Golgi apparatus in the same way (Fig. 7, A and B, bottom). These 
results suggest that the association of Lyn with the Golgi apparatus may be unaffected by the mutation in the 
C-lobe. 
   To examine whether the four negative-charged residues in the C-lobe were involved in transport of Lyn from 
the Golgi apparatus to the plasma membrane and/or accumulation of Lyn at the Golgi apparatus, we constructed 
the GFP-tagged version of Tetra-mt (Tetra-mt-GFP) by replacing Asp-346, Glu-353, Asp-498, and Asp-499 
present in the C-lobe of Lyn-GFP with four alanines. The pattern of localization of Tetra-mt-GFP to the Golgi 
apparatus was indistinguishable from that of Tetra-mt (unpublished data; Fig. 6F). Then, we compared the 
trafficking of Lyn-GFP with that of Tetra-mt-GFP. Using FRAP, fluorescence recovery of Lyn-GFP or 
Tetra-mt-GFP was simultaneously monitored in both the perinuclear region (Fig. 7, C and D, circled area) and 
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the plasma membrane (Fig. 7, C and D, boxed area) after whole cell area was photobleached. Fig. 7C shows that 
rapid recovery of Lyn-GFP fluorescence was observed in the perinuclear region (circle area). This rapid response 
was similar to that of fluorescence recovery of Tetra-mt-GFP in the perinuclear region (Fig. 7D, circled area). 
The plateau levels in fluorescence recovery were also comparable between Lyn-GFP and Tetra-mt-GFP (Fig.7, C 
and D, circled area). In sharp contrast to the perinuclear region, the rate of fluorescence recovery of 
Tetra-mt-GFP at the plasma membrane (Fig. 7D, boxed area) greatly decreased as compared with that of 
Lyn-GFP at the plasma membrane (Fig. 7C, boxed area). These results suggest that the mutation of the four 
negative-charged residues is unlikely to affect the association of Lyn at the Golgi apparatus just after 
biosynthesis. Rather, the mutation markedly impeded the trafficking of Lyn from the Golgi apparatus toward that 
plasma membrane. These results implicate that the four negative-charged residues on the C-lobe may be 
involved in an export process of Lyn form the Golgi apparatus. 
 
Discussion 
   Here, we demonstrate that the kinase domain of Lyn plays a significant role in Lyn trafficking besides 
catalysis of substrates phosphorylation. By using FRAP and immunostaining for pursuing spatial and temporal 
localization of Lyn, we show that newly synthesized Lyn is accumulated at the Golgi pool of caveolin and then 
transported to the plasma membrane in a kinase domain-dependent manner but kinase activity independent 
manner. Furthermore, we have identified four negative-charged amino acid residues in the C-lobe of the kinase 
domain as being important for transport of Lyn from the Golgi apparatus toward the plasma membrane. 
   It is well known that nonreceptor-type tyrosine kinases contain modular domains for protein-protein 
interactions, such as the SH2 and SH3 domains (30). In the repressed state, the SH2 and SH3 domains of 
Src-family kinases and of Abl tyrosine kinase can confer their autoinhibited “closed conformation” through 
intramolecular interactions (4, 5, 31, 32). In the activated state, these modular domains exposed by an “open 
conformation” can interact with adaptor or substrate proteins, thereby transmitting signals downstream. It should 
be noted that the trafficking of Lyn can be inhibited by Csk-mediated phosphorylation of COOH-terminal 
tyrosine residue of Lyn (Fig. 4, A-C). Nonetheless, the trafficking of the kinase-inactive Lyn mutant obviously 
proceeds to the plasma membrane (Fig. 4). Therefore, we assume a novel Csk-induced mechanism for inhibition 
of Lyn trafficking, independently of the kinase-activity inhibition, which could not be explained by the 
well-established autoinhibitioin mechanism (3, 33-35). Mutational analyses further reveals that the four 
negative-charged amino acid residues of the C-lobe in the kinase domain which may exposed to the molecular 
surface in an “ open conformation” (Fig. 6A), is involved in the trafficking of Lyn from the Golgi apparatus to 
the plasma membrane (Fig. 6F and Fig. 7). Accordingly, we hypothesized that an “open conformation” of Lyn 
unmasks the αE and αI helices within the C-lobe of the kinase domain including the four negative-charged 
amino acid residues that may function for the proper trafficking through potential protein-protein interactions. 
   Treatment with BFA disperses the Golgi localization of Lyn, accompanied by disassembly of the Golgi 
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apparatus (Fig. 2E; Fig. 7, A and B), suggesting that the transport of Lyn to the plasma membrane may share 
membrane transport via the Golgi apparatus in the secretory pathway. The observations of whole cell bleaching 
in FRAP experiments indicate that the localization of Lyn to the Golgi apparatus actually requires protein 
synthesis (Fig. 3B), suggesting that Lyn already transported to the plasma membrane does not move back from 
the plasma membrane to the Golgi apparatus. Intriguingly, the export of Lyn from the Golgi apparatus to the 
plasma membrane is specifically inhibited by treatment with NEM (Fig. 3, C and D), further indicating that the 
transport is assisted with membrane vesicles of the exocytic pathway. The C-lobe of the kinase domain is 
involved in export of Lyn from the Golgi apparatus to the plasma membrane (Fig. 6 and 7), whereas the SH4, 
unique, SH3, and SH2 domains are not (Fig. 5). Together, we can imagine that localization of Lyn to the Golgi 
apparatus is prerequisite for its trafficking to the plasma membrane along the exocytic vesicular transport 
pathway, i.e., one-way or vectorial trafficking of Lyn through the Golgi apparatus. Perhaps the C-lobe may 
actively participate in and accelerate an export process on the cytoplasmic side of the vesicles at the Golgi 
apparatus, because Lyn must be anchored on the outer surface of membrane vesicles through lipid modification. 
Alternatively, given that accumulation of newly synthesized Lyn at the Golgi apparatus can reach a plateau at 
similar rates and levels irrespective of the mutation of four negative-charged residues on the C-lobe (Fig. 7, C 
and D), Lyn might be protected from proteolytic degradation in the Golgi milieu due to the negative-charged 
residues on the C-lobe. Further studies will decipher a precise role of C-lobe in Lyn trafficking. 
   Caveolins form lipid-raft platforms of a variety of signaling molecules at the plasma membrane and are 
important for transporting cholesterol and glycosylphosphatidylinositol-linked proteins (36). Caveolins are also 
involved in endocytic and exocytic transport (25, 37, 38). Caveolin-containing endosomes are implicated as sites 
for the sorting of caveolin away from the Golgi-bound cargos (25). Our cross sections of the confocal images 
demonstrate that Lyn colocalizes with caveolin at the Golgi apparatus (Fig. 2, A and B). It is of substantial 
interest to note that minimal colocalization of Lyn with caveolin is detected at the plasma membarane despite 
flawless colocaliztion of Lyn with caveolin at the Golgi apparatus (Fig. 2, Band C). Although a role of caveolin 
in Lyn trafficking is still unclear, Lyn may be dissociated from caveolin-containing vesicles during transport of 
Lyn from the Golgi apparatus en route to the plasma membrane. 
   Mutation of the COOH-terminal tyrosine residue or deletion of the kinase domain of c-Src was reported to 
dramatically redistribute c-Src from perinuclear endosomal membranes to focal adhesions (39), suggesting that 
the SH2 domains of c-Src in an “open conformaiton” can be exposed for association with focal adhesions. 
However, despite the presence of the SH4, unique, SH3, and SH2 domains, the localization of the kinase 
domain-deleted Lyn (Lyn Δ K-HA) to the perinuclear region (Fig. 1) is quite a different from that of the kinase 
domain-deleted c-Src to focal adhesions. Even though the COOH-terminal negative-charged amino acid residues 
on Lyn is mutated for formation of an activated “open conformation”, the patterns of localization of Lyn-HA is 
dissimilar to that of corresponding mutant of c-Src (Fig. 1; for review see 39). Thus far, it has been reported that 
c-Src, Lck, Fyn, Hck, and c-Yes are enriched in the perinuclear region (8-10, 13-15, 18, 40). In our view 
 9
emerged from literature surveys, the localization of Lck and Hck to the perinuclear region seem to be similar to 
the restricted localization of Lyn shown in this work, whereas c-Src and c-Yes appear to be more widely 
distributed around the nucleus. In fact, we observed minimal colocalization of c-Src with caveolin in the 
perinuclear region and no elimination of c-Src from the perinuclear region by inhibition of protein synthsis (Fig. 
2, C and D; unpublished data). These results raise the intriguing possibility that two close relatives, Lyn and 
c-Src, localize to at least two different subcellular organelles in the perinuclear region, i.e., the Golgi pool of 
caveolin and caveolin-negative endosomes, for their presumable distinct functions. 
   Why does newly synthesized Lyn initially localize and accumulate at the Golgi apparatus? Recent evidence 
provides a novel view that endomembranes, such as the Golgi apparatus and the ER, may serve as a platform of 
signaling molecules. For example, Ras that is restricted to the endomembranes can activate the Erk pathway in 
response to mitogenic stimulation and play a role in transformation of fibroblasts (41). It is also observed that 
phosphatidylinositol-3, 4, 5-triphosphate levels are increased to a larger extent at the endomembranes than at the 
plasma membrane, which is triggered by endocytosed receptor tyrosine kinases (42). Therefore, it would be 
tempting to assume that accumulation of Lyn at the Golgi apparatus is important in unidentified signal 
transduction at endomembranes. Alternatively, previous studies with T cells suggested that Lck can associate 
with the cytoplasmic domain of cell surface transmembrane protein CD4 at the Golgi apparatus early after 
synthesis or long before CD4 has reached the plasma membrane (15, 17). In addition, dual myristoylation and 
plamitoylation are needed for membrane association, because myristoylated proteins are either soluble or only 
weekly associated with membranes (43) after the covalent attachment of myristic acid to NH2-terminal glycine at 
the amino acid position 2 occurs cotranslationally in the cytoplasm (44). Another possibility may be addressed 
that a site of palmitoylation of Lyn might be located in the Golgi apparatus because a species of palmitoyl 
acyltransferase is hypothesized to reside at the Golgi apparatus (45). Although these possibilities are mutually 
inclusive, further studies will be required to understand a key role for localization of Lyn to the Golgi apparatus 
besides the plasma membrane. 
   It is clear from this work that transport of Lyn to the plasma membrane is far more complex than initially 
thought. It should be emphasized that a structure of the kinase domain per se plays a novel role for Lyn 
trafficking. At present, it is particularly interesting to determine how an “open conformation” of the kinase 
domain operates during protein trafficking. In addition, the mechanisms of trafficking should be compared 
between Lyn and c-Src for further understanding of different localizations of these Src-family kinases. 
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Figure 1 
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Figure 1. Perinuclear localization of Lyn and its mutants.
(A) Schematical representations of Lyn and its mutants are shown with the Src homology (SH) domains, the
negative-regulatory tyrosine (Y), and the HA-epitope tag. HeLa cells inducibly expressing Lyn-HA (B) or Lyn∆K-
HA (C) were cultured in the absence (inset) or presence of 1 µg/ml doxycycline for 2 d, and stained with anti-HA.
Lyn, green; DNA, red. Bars, 20 µm. HeLa cells inducibly expressing Lyn-HA (D) or Lyn∆K-HA (E) were cultured
in the presence of 3 µg/ml doxycycline for the indicated periods, and stained with anti-HA. Cells exhibiting the
perinuclear localization of Lyn as seen in C were quntified. Results (%) are the mean ± SD from three independent
experiments. Protein expression was not clearly detected at 3 hr after induction. (F) COS-1 cells transfected with
Lyn and its mutants were cultured for 24 hr, stained with anti-Lyn. Four patterns of Lyn localization are shown:
PeriN>>PM (a, a'), PeriN>PM (b, b'), PeriN≤PM (c, c'), and PeriN<<PM (d, d'), as described under “Experimental
Procedures”. PeriN, perinuclear region; PM, plasma membrane; Lyn, green; DNA, red. Bars, 20 µm. (G) A
representative analysis of each Lyn mutant is shown. COS-1 cells transfected with Lyn (a), Lyn-HA (b), or Lyn K-
HA (c) were cultured for the indicated periods. Lyn localization was quantified according to the classification as
described in F. PeriN, filled bars; PM, open bars. Protein expression was not detected until 11 h after transfection.
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Figure 2. Colocalization of Lyn with the Golgi pool of caveolin at the perinuclear region.
COS-1 cells were transfected with Lyn, and stained with anti-Lyn (red) in conjunction with (A) anti-
galactosyltransferase (anti-GalT; green) or (B) anti-caveolin (green). All Z-series sections at 0.3-0.5-µm intervals were
merged in two-dimensional xy images. Orthogonal sections viewing axial directions (xz and yz) are created in the
margins. (C and D) COS-1 cells transfected with Lyn-HA were cultured for 18 h in the presence or absence of 200
µg/ml CHX during the last 3 h. Cells were double stained with anti-Lyn (red) and anti-caveolin (green). (D) Cells
exhibiting the perinuclear localization of Lyn were quantified. Results (%) are the mean ± SD from three independent
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were double stained with anti-Lyn (red) and anti-GalT (green). N, nucleus. Bars, 20 µm.
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Figure 3. Lyn trafficking through the Golgi pool of caveolin after biosynthesis.
Lyn trafficking was visualized in living COS-1 cells that were transfected with Lyn-GFP and cultured for 1 d. (A, a) Whole
area of a cell was bleached, and the cell was monitored for the next 50 min at 20-s intervals. Times are shown from
completion of the photobleaching. (b) Quantification of fluorescence recovery in the perinuclear region (circled area) and
the plasma membrane (boxed area). Mean fluorescence intensities of recovery after photobleaching are plotted versus time.
(B) (a) The perinuclear region (circled area) was bleached, and then the cell was monitored for the next 40 min at 20-s
intervals in the absence or presence of 200 µg/ml CHX from 1 h before bleaching. (b) Quantification of fluorescence
recovery in the perinuclear region (circled area). (C, a) Whole cell area excluding the perinuclear region was bleached, and
then the cell was monitored for the next 30 or 60 min at 2-min intervals in the absence or presence of 300 µM NEM from 15
min before photobleaching. (b) Quantification of fluorescence recovery in the plasma membrane (boxed areas). (D) Whole
cell area including the perinuclear region was bleached, and then the cell was cultured for 60 min in the presence of 300 µM
NEM from 15 min before photobleaching. N, nucleus. Bars, 20 µm.
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Figure 4. Inhibition of Lyn trafficking by
Csk, but not by Lyn inactivation. (A) COS-1
cells transfected with Lyn, Lyn plus Csk, Lyn-HA, or
Lyn(K275A)-HA were cultured for 24 h, and stained
with anti-Lyn or anti-HA. COS-1 cells transfected
with Lyn were cultured for 24 h, and treated with or
without 10 M PP2. Lyn localization was classified as
described in Fig. 1 F. Results (%) are the mean ± SD
from three independent experiments. COS-1 cells
transfected with Lyn-HA plus Csk were cultured for
24 h. Results (%) of a representative experiment are
shown for localization of Lyn-HA. PeriN, filled bars;
PM, open bars. (B) COS-1 cells transfected with Lyn
(a) or Lyn plus Csk (b) were cultured for 24 h, and
stained with anti-Lyn. Arrows indicate cells expressing
Lyn. Lyn, green; DNA, red. Bars, 20 µm. (C) Lyn
immunoprecipitates prepared from COS-1 cells
transfected with Lyn or Lyn plus Csk were subjected
to in vitro kinase assays. Kinase reactions were
determined by probing with anti-pTyr, and amounts of
Lyn immunoprecipitates were analyzed by subsequent
reprobing with anti-Lyn. The levels of tyrosine
phosphorylation of enolase relative to the amounts
of Lyn at each reaction time were quantified. Results
are the mean ± SD from three independent kinase
assays. (D) COS-1 cells were transfected with Lyn-HA
or Lyn(K275A)-HA and cultured for 48 h. (Top)
Western blot of equal amounts of Triton X-100 lysates
was probed with anti-pTyr, and subsequently reprobed
with anti-Lyn. The positions of size markers in
kilodaltons are shown on the right. (Bottom)
Immunoprecipitates of Lyn mutants with anti-HA were
probed with anti-pTyr, and amounts of the
immunoprecipitates were analyzed by subsequent
reprobing with anti-HA.
Figure 5. Involvement of the COOH-terminal
kinase lobe in Lyn trafficking. (A) Schematic
representations of Lyn-HA and its deletion mutants are
shown. COS-1 cells were transfected with each of Lyn
mutants, and cultured for 48 h. Western blots of equal
amounts of Triton X-100 lysates were probed with anti-
Lyn or anti-HA. Asterisks indicate the expressed proteins.
(B) After transfection with each of Lyn mutants, COS-1
cells were cultured for 48 h. Results (%) of localization of
Lyn mutants are the mean ± SD from three independent
experiments, as described in Fig. 1 F. (C) Results (%) of
localization of 121-324 at 12 and 48 h after transfection
into COS-1 cells are shown from a representative and
three independent experiments, respectively. PeriN, filled
bars; PM, open bars.
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Figure 6. Inhibition of Lyn trafficking by mutation of four charged amino acid residues.
(A) Src structure in the inactive state, represented by the SH3 (green) and SH2 (yellow) domains, the SH2
linker (red), the NH2-terminal (light blue) and COOH-terminal (purple) kinase lobes, and the COOH-terminal
tail (orange). (B) The interaction of the COOH-terminal kinase lobe and the SH2 domain via positively
(green) and negatively (red) charged side chains in Hck. The figures (A and B) are modified from Sicheri et
al. (1997) and Williams et al. (1998). (C) Amino acid sequence alignment of the Src family, the Csk family
(Csk and Chk), c-Abl, insulin receptor kinase (IRK), fibroblast growth factor receptor kinase (FGFRK), and
cAMP-dependent protein kinase (PKA). Positively and negatively charged residues are shown in green and
red, respectively. (D) Schematic representations of Lyn-HA and its alanine-substitution mutants are shown.
(E) COS-1 cells were transfected with Lyn mutants, and cultured for 48 h. Western blot of equal amounts of
Triton X-100 lysates was probed with anti-pTyr, and subsequently reprobed with anti-HA and antiactin. (F)
COS-1 cells (left) or HeLa cells (right) were transfected with Lyn mutants, and cultured for 48 h. Results (%)
of Lyn localization are the mean ± SD from three independent experiments, as described in Fig. 1 F. PeriN,
filled bars; PM, open bars.
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Figure 7. Involvement of the
four charged residues in
transport of Lyn from the
Golgi to the plasma
membrane. COS-1 cells
transfected with Lyn-HA (A) or
Tetra-mt (B) were cultured for 1 d in
the absence or presence of 5 µg/ml
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Materials and Methods 
Plasmid Constructs  
Lyn lacking the kinase domain (Lyn ΔK, 1-298; the number referring to the amino acid position from the 
initiator methionine) was constructed (22) from human wild-type p56 Lyn cDNA (46; provided by Dr. T. 
Yamamoto, University of Tokyo). LynΔK was ligated into the pMH vector (Roche), resulting in the HA-tagged 
version (LynΔK-HA). The HA-tagged kinase-active Lyn (Lyn-HA) was designed to replace the C-terminal 
negative regulatory region (507-512 containing Tyr508) with the HA epitope by PCR using the sense primer 
5’-AGATGAGCTCTATGACATTATGAA-3’ and the antisense primer 5’-TTTCTAG 
AGTCTAAGCGTAGTCTGGGACGTCGTATGGGTAACCTTCCGTGGCTGTGTAGAAA-3’. The Lys?Ala 
mutation at position 275 in the ATP-binding site (kinase-inactive, K275A) was generated by site-directed 
mutagenesis according to the protocol (Stratagene) with Lyn-HA as a template using the sense primer 
5’-CTATAACAACAGTACTAAGGTGGCTGTGGCAACCCT GAAGCCAGG-3’ and the antisense primer 
5’-CCTGGCTTCAGGGTTGCCACAGCCACCTTA GTACTGTTGTTATAG-3’. Lyn-DE-mt (Asp346?Ala, 
Glu353?Ala) and Lyn-DD-mt (Asp498?Ala, Asp499?Ala) were created using Lyn-HA as a template with the 
respective primer combinations: the sense primer 5’-CAAAGCTCATTGCCTTTTCTGCGCAGATTGCAG 
CGGGAATGGCATAC-3’ and the antisense primer 5’-GTATGCCATTCCCGCTGCAATCTGCG 
CAGAAAAGGCAAGAGCTTTG-3’, or the sense primer 5’-GACTACTTACAGAGCGTGCTA 
GCTGCTTTCTACACAGCCACGG-3’ and the antisense primer 5’-CCGTGGCTGTGTAGAAA 
GCAGCTAGCACGCTCTGTAAGTAGTC-3’. Lyn-Tetra-mt (Asp346?Ala, Glu353?Ala, Asp498?Ala, 
Asp499?Ala) was constructed from Lyn-DE-mt and Lyn-DD-mt. Lyn-Leu456stop (1-456), Lyn-Asp367stop 
(1-367), LynΔ (296-457)-HA (1-295 and 458-506), LynΔ (227-298)-HA (1-226 and 299-506), and LynΔ 
(121-324)-HA (1-120 and 325-506) were generated from Lyn-HA using appropriate restriction enzymes and 
blunting. The resulting fragments were all confirmed by sequencing. Lyn-GFP and Lyn-Tetra-mt-GFP was 
constructed by fusion with the GFP obtained from pEGFP-C1 (Clontech) at the C-terminus of Lyn-HA and 
Lyn-Tetra-mt, respectively. The constructs were subcloned into the pMKITneo vector (provided by Dr. K. 
Maruyama, Tokyo Medical and Dental University) or the tetracycline-inducible pcDNA4/TO vector (Invitrogen). 
Rat Csk cDNA (47; provided by Dr. M. Okada, Osaka University), tagged with the HA-epitope at the C-terminus 
into the pMH vector (Csk-HA, 1-440), was ligated into the pCAG vector (48; provided by Dr. J. Miyazaki, 
Osaka University). 
 
Antibodies 
Monoclonal anti-HA (F-7, Santa Cruz Biotech, and 3F10, Roche), anti-Lyn (H-6, Santa Cruz Biotech), 
anti-phosphotyrosine (anti-pTyr) (4G10, Upstate Biotech), and anti-actin (MAB1501, Chemicon) were used. 
Affinity-purified rabbit anti--1,4-galactosyltransferase (49) (provided by Dr. M.N. Fukuda, The Burnham 
Institute), anti-Lyn (H-44, Santa Cruz Biotech), and anti-caveolin (Transduction) were used. Horseradish 
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peroxidase-F(ab’)2 of antibodies to mouse, rat or rabbit Ig were purchased from Amersham. FITC-F(ab’)2 of 
anti-rabbit IgG or anti-mouse IgG and TRITC-anti-mouse IgG were obtained from BioSource and Sigma. 
 
Cells and Transfection 
COS-1 cells were cultured in Iscove’s modified Dulbecco’s medium (IMDM) containing 5% fetal bovine serum 
(FBS). T-RExTM-HeLa cells (Invitrogen) that express the tetracycline repressor were maintained in IMDM 
containing 5% FBS and 0.2 μg/ml blasticidin, and cells were transfected with the pcDNA4/TO vector 
(Invitrogen) encoding Lyn∆K-HA or Lyn-HA using the TransIT Transfection Reagent (Mirus) (50), and cell 
clones were selected in 250 μg/ml Zeocin (Invitrogen) plus 0.2 μg/ml blasticidin. Doxycycline (Dox), a 
derivative of tetracycline, was used for protein expression. COS-1 cells were transfected with 0.2 μg or 1.0 μg of 
plasmid vectors using TransIT. For inhibition of Lyn, COS-1 cells transfected with Lyn were cultured for 6 hr, 
and treated with PP2 (Calbiochem, 51) for the next 18 hr. 
 
Immunofluorescence 
Cells were fixed with 4% paraformaldehyde, and permeabilized with 0.1% saponin (50, 52). Confocal and 
Nomarski differential-interference-contrast images were obtained using an LSM510 (Zeiss) or FLUOVIEW 
FV500 (Olympus) laser scanning microscope. Care was taken to ensure that detection sensitivity was kept 
constant and that there was no bleed-through from the fluorescein signal into the red channel (50). One planar 
(xy) section slice was shown in most experiments. Orthogonal sections viewing axial directions (xz and yz) were 
created when all Z-series sections at 0.25-0.5 μm intervals were merged. 100800 cells were scored for each 
assay according to whether expressed proteins were restricted in the perinuclear region (PeriN>>PM), higher 
distributed in the perinuclear region (PeriN>PM), evenly distributed between the perinuclear region and plasma 
membrane or higher at the plasma membrane (PeriN≤PM), or restricted at the plasma membrane (PeriN<<PM). 
Results (%) were expressed as ratios of number of cells exhibiting these classified localizations to total number 
of cells expressing Lyn proteins. 
 
Photobleaching Experiments 
COS-1 cells were transfected with GFP-tagged versions and cultured for 1 day. Photobleaching experiments 
were performed on a stage of a FLUOVIEW FV500 laser scanning microscope using the 488 nm line of an 
argon laser in conjunction with a 40X oil immersion objective to achieve sufficient depth for bleaching z. The 
circled area or whole area was photobleached at full laser power (100% power) and recovery of fluorescence was 
monitored by scanning the whole cell at low laser power (3.0% power). Time-lapse sequences were recorded 
with FLUOVIEW TIEMPO and the mean or integrate fluorescence intensities within regions of interest were 
quantitated using FLUOVIEW TIEMPO time course software Ver. 4.2. 
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Western blotting and Immunoprecipitation 
Lysates were prepared in Triton X-100 lysis buffer (50 mM HEPES, pH 7.4, 10% glycerol, 1% Triton X-100, 4 mM 
EDTA, 100 mM NaF and 1 mM Na3VO4) containing 50 μg/ml aprotinin, 200 μg/ml leupeptin, 50 μM pepstatinA, and 
2 mM phenylmethylsulfonyl fluoride. Immunoprecipitation was performed using anti-Lyn- or anti-HA-precoated 
Protein-G beads. Immunodetection was performed, as reported (22, 53). 
 
In Vitro Kinase Assay  
In vitro kinase assays were performed as described (22, 50, 54, 55). In brief, wild-type Lyn was 
immunoprecipitated with anti-Lyn from Triton X-100 lysates of COS-1 cells transfected with wild-type Lyn or 
wild-type Lyn plus Csk. After washing, equal amounts of each immunoprecipitate were reacted with enolase in 
kinase buffer (50 mM HEPES, pH 7.4, 1% Triton X-100, 10 mM MnCl2, 1 mM Na3VO4) containing 100 μM 
ATP at 30 oC for the indicated periods. Phosphorylated bands were quantified with the Image Gauge software 
using an Image Analyzer LAS-1000plus (Fujifilm). 
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Part II 
Palmitoylation regulates late endosome/lysosome-routed 
Src cycling and lysosomal biogenesis 
 
Abstract 
Src-family kinases (SFKs) are involved in various signalings at the plasma membrane (PM). SFKs are 
coexpressed with multiple combinations, but little is known about the spatio-temporal relationship among 
SFKs. Here, we show that palmitoylation, which is postulated to regulate SFK signalings, controls the 
functional specificity and redundancy of SFKs through dynamic alteration of the intracellular trafficking 
pathway of SFKs. Time-lapse microscopy combined with photobleaching techniques reveals that c-Src, 
which is not palmitoylated, rapidly cycles between late endosomes/lysosomes and PM mediated by 
clathrin-dependent endocytosis and atypical exocytosis. Cycling c-Src can be anchored to focal adhesions 
and lipid rafts when the SH2 domain becomes freely available. Although palmitoylated Lyn traffics to PM 
via the Golgi apparatus, nonpalmitoylation changes the trafficking of Lyn to the c-Src-type cycling. c-Src 
and nonpalmitoylated Lyn, unlike palmitoylated SFKs, are involved in controlling fusion/aggregation of 
Rab7-associated endosomes in an SH2 domain-dependent manner. Thus, coexpressed SFKs exert specific 
and overlapping functions through two different trafficking pathways distinguished by palmitoylation. 
 
 
Introduction 
   Src-family tyrosine kinases (SFKs), classified as cytosolic enzymes, comprise proto-oncogene products and 
structurally related proteins, and include at least eight members with significant amino acid sequence homology 
(c-Src, Lyn, Fyn, c-Yes, c-Fgr, Hck, Lck, and Blk) (1, 3). SFKs are activated by various stimuli, including 
growth factors and adhesion proteins, and are involved in a wide range of signaling events at the plasma 
membrane (PM), resulting in cell proliferation, differentiation, migration, and cytoskeletal reorganization. 
Overexpression and enhanced activity of SFKs found in a large number of human malignancies have been linked 
to the development of cancer and progression to metastases (56, 57), and there has recently been a renewed 
interest in SFKs as molecular targets for cancer therapy (58). 
   SFKs are composed of: an NH2-terminal Src homology (SH) 4 domain that contains lipid modification sites 
for myristoylation mostly together with palmitoylation; a poorly conserved “unique” domain; an SH3 domain, 
which can bind to specific proline-rich sequences; an SH2 domain, which can bind to specific sites of tyrosine 
phosphorylation; an SH1 tyrosine kinase catalytic domain; and a negative regulatory tail for autoinhibition of 
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kinase activity (1, 3). SFKs can interact with a large number of upstream regulators and downstream substrates 
by protein-protein interactions (1, 3). Multiple combinations in expression of SFKs in a single cell are implicated 
to serve specific and overlapping functions (1-3, 59-66). It is generally thought that SFKs are predominantly 
located at the cytoplasmic face of PM through posttranslational myristoylation, but in fact their appreciable 
fractions are found at a variety of intracellular locations besides PM, which may correspond to associate with 
endosomes, synaptic vesicles, secretory granules/phagosomes, the Golgi apparatus, and so on (1, 3, 9-13, 17, 67). 
Such distinctive localizations of SFKs have therefore suggested that the mechanism for localizations of SFKs 
may be far more complicated than simply thought (3). 
   In this study, we analyze the spatio-temporal relationship among SFKs by confocal laser microscopy, and 
show that c-Src, which is not palmitoylated, is rapidly cycling between late endosomes/lysosomes (LE/Lyso) and 
PM. The cycling of c-Src is distinct from the exocytic trafficking of Lyn, which is palmitoylated, to PM via the 
Golgi apparatus (67). We further show that nonpalmitoylation allows Lyn to rapidly cycle between LE/Lyso and 
PM. c-Src and nonpalmitoylated Lyn, both of which are cycling between LE/Lyso and PM, can be recruited to 
signaling platforms such as focal adhesions. Moreover, nonpalmitoylated SFKs but not palmitoylated SFKs are 
involved in controlling membrane fusion of Rab7-associated vesicles for lysosome biogenesis in a kinase 
activity-independent manner. Our findings demonstrate the existence of the two major trafficking pathways for 
SFKs that are distinguished by palmitoylation and nonpalmitoylation. These distinct trafficking pathways for 
SFKs may provide a clue to explain an enigma of various subcellular localizations of individual SFK members 
for their functions. 
 
Results 
c-Src is rapidly cycling between LE/Lyso and PM 
   To scrutinize the difference in localizations of individual SFKs in unstimulated cells, we compared the 
steady-state distributions of c-Src and Lyn that are endogenously coexpressed in HeLa and COS-1 cells. 
Although c-Src and Lyn were distributed to the perinuclear region as well as PM, localizations of organelle 
markers, such as the LE/Lyso-resident protein Rab7 (68), the lysosomal enzyme cathepsin D and the PM–Lyso 
cycling protein CD63 (69, 70), the trans-Golgi resident β-1,4-galactosyltransferase (GalT), and the trans-Golgi 
network (TGN)-enriched cation-independent mannose 6-phosphate receptor (MPR) (71), showed that c-Src 
present in the perinuclear region was colocalized to a high degree with LE/Lyso but outwardly with the 
TGN–Golgi apparatus (Figs. 8A-C and S1A-B), consistent with previous observations that a large fraction of 
c-Src localizes to endosomal membranes (10). In sharp contrast, Lyn present in the perinuclear region was 
mostly colocalized with GalT but minimally with Rab7 (Figs. 8D and 15E). In particular, Lyn but not c-Src was 
colocalized with the Golgi pool of caveolin (67; data not shown). Therefore, these results establish that the 
localization of c-Src is quite distinct from that of Lyn. 
   To follow the intracellular itinerary of c-Src in living cells, we constructed the Src-GFP (green fluorescent 
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protein) fusion protein that preserves the almost entire structure of c-Src containing the NH2-terminal lipid 
attachment site (Fig. 12A). The localization of Src-GFP visualized by fluorescence of GFP was consistent with 
that of intact c-Src (Figs. 8A-B and S1C-D). Using fluorescence recovery after photobleaching (FRAP) 
techniques, the trafficking of Src-GFP was monitored in living cells transfected with Src-GFP. When the area of 
LE/Lyso in a Src-GFP–transfected cell was photobleached (Fig. 9A), fluorescence recovery of Src-GFP in 
LE/Lyso was rapid and reached a steady-state plateau within 4~5 min (enclosed area), whereas Src-GFP 
fluorescence slightly decreased in PM (LE/Lyso-excluded area). These rapid responses were similar to those of 
Src-GFP fluorescence seen in cells treated with cycloheximide (CHX), an inhibitor of protein synthesis (Fig. 9B, 
left), indicating no requirement of protein synthesis for these responses. Replotting with data obtained as 
integrated fluorescence intensity revealed that a rapid increase in fluorescence intensity of Src-GFP in 
LE/lysosomes was inversely proportional to a rapid decrease in that at PM (Fig. 9B, right). When whole cell 
area excluding LE/Lyso was photobleached in the presence of CHX, Src-GFP fluorescence was rapidly dispersed 
from LE/Lyso to PM (Fig. 9C). The half times for fluorescence recovery obtained in the presence of CHX 
indicate that the rate of the inward movement of Src-GFP from PM to LE/Lyso similarly corresponds to that of 
the outward movement from LE/Lyso to PM (Fig. 9B-C). However, when a peripheral PM area outside LE/Lyso 
was photobleached, fluorescence recovery of Src-GFP in the peripheral PM area was almost instant probably due 
to lateral diffusion of Src-GFP, and reached a steady-state plateau at only ~1 min (Fig. S1E, enclosed area). 
Taken together, these results suggest that Src-GFP is constitutively cycling between LE/Lyso and PM. 
 
Rapid cycling of c-Src is driven by clathrin-mediated endocytosis and calcium-independent 
exocytosis 
   Endocytic recycling generally involves clathrin-coated pit internalization of proteins from PM, fusion of 
newly formed endosomes containing internalized proteins with pre-existing early endosomes (EE), and delivery 
of the proteins associated with resulting EE toward PM (72). Proteins at PM that are destined for proteolytic 
degradation are endocytosed into EE, which mature into LE and further into Lyso by fusion events. LE and Lyso 
are not on the main endocytic recycling route, although the only known pathways from Lyso to PM are 
microtubule-dependent, calcium-regulated exocytosis of conventional and secretory lysosomes (73, 74). 
   To understand the endocytic pathway from PM to LE/Lyso in cycling of c-Src, the area of LE/Lyso was 
photobleached in the presence of various inhibitors. Fluorescence recovery of Src-GFP in LE/Lyso was 
efficiently blocked by treatment with N-ethyl-maleimide (NEM) (a reagent known to block a wide range of 
vesicle fusion events; 27) (Fig. 10A), but was not affected by treatment with brefeldin A (a Golgi-dispersing 
drug; 26), nocodazole (a microtubule-depolymerizing drug), cytochalasin D (an actin filament-depolymerizing 
drug), taxol (a microtubule-stabilizing drug), wortmannin (a PI-3 kinase inhibitor that blocks fluid-phase 
endocytosis; 75), serum starvation (inhibition of growth factor-receptor internalization), or PP2 (an inhibitor of 
SFKs) (Figs. 10B-D and S2; data not shown). Furthermore, FRAP experiments showed that accumulation of 
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Src-GFP in LE/Lyso was suppressed by inhibition of clathrin-dependent endocytosis through K+ depletion (Fig. 
10E; 76) or expression of dominant-negative AP180-C (the clathrin-binding C-terminal domain of AP180; 77, 
78 (Fig. 10F). These results indicate that the inward movement of c-Src from PM to LE/Lyso involves vesicle 
fusion events and clathrin coats, but this inward movement is not dependent on the Golgi, formation of 
microtubules and actin filaments, fluid-phase endocytosis, receptor internalization, and activation of SFKs. 
Although c-Src seems partly associated with the Golgi (Figs. 8C and S1B), it is likely that the vesicle trafficking 
via the Golgi does not participate in cycling of c-Src. In addition, the existence of a yet-unidentified cycling 
pathway, which is independent of clathrin-mediated endocytosis, is implicated from the remaining fluorescence 
of perinuclear c-Src in AP180-C-expressing cells (Fig. 10F). 
   Furthermore, to analyze the exocytic pathway from LE/Lyso to PM in cycling of c-Src, whole cell area 
excluding LE/Lyso was photobleached in the presence of various inhibitors. Fluorescence recovery of Src-GFP 
from LE/Lyso to PM was blocked by treatment with NEM but not by treatment with brefeldin A, nocodazole or 
BAPTA-AM (a membrane-permeable calcium chelator; 79) (Fig. 11), indicating that the outward movement of 
c-Src requires vesicle fusion events but is not dependent on the secretory pathway via the Golgi apparatus, 
microtubule polymerization and calcium mobilization.  
   Moreover, recent data provide evidence that after growth factor or integrin stimulation a small fraction of 
c-Src is translocated from perinuclear membranes to the cell periphery at filopodia and ruffling membranes in a 
manner that is dependent on actin polymerization (80, 81). However, our data show that cycling of c-Src, which 
appears to take place throughout the whole area of PM, was not affected by inhibition of actin polymerization 
(Fig. 10D). Taken together, we conclude that under unstimulated conditions a majority of c-Src is continuously 
cycling between LE/Lyso and PM by means of vesicle transport. Therefore these data suggest that cycling of 
c-Src between LE/Lyso and PM is largely driven by clathrin-mediated endocytosis and novel 
calcium-independent exocytosis. 
 
c-Src is immobilized on signaling platforms through the SH2 domain freely accessible to signaling 
molecules 
   Next, to test the hypothesis that cycling c-Src between LE/Lyso and PM can be recruited to the stationary 
signaling platforms through the SH3 and SH2 domains by an open, active conformation for protein-protein 
interactions, we constructed a GFP-fused kinase-deleted c-Src mutant, Src308-GFP (Fig. 12A), which is released 
from steric hindrance of the kinase domain for sufficient protein-protein interactions. Unlike Src-GFP, 
Src308-GFP was distributed to many scattered dots together with LE/Lyso in COS-1 (Fig. 12B) and HeLa cells 
(Fig. 12F-H), consistent with previous reports (82-84). FRAP experiments showed that, after the perinuclear 
region was photobleached, the recovery levels of Src308-GFP fluorescence were suppressed (Fig. 12B). 
However, fluorescence recovery of Src308∆SH2-GFP but not Src308∆SH3-GFP was rapid and full in LE/Lyso, 
similar to that of Src-GFP (Figs. 12B-D and 9A; compare respective half-times for fluorescence recovery). 
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Additionally, in situ extraction with Triton X-100 (TX100) under a confocal laser microscope showed that most 
of Src308-GFP and Src308∆SH3-GFP were resistant to extraction with TX100 despite the fact that Src-GFP and 
Src308∆SH2-GFP was extracted efficiently (Fig. 12F). TX100-resistant Src308-GFP was considerably 
colocalized with vinculin (Fig. 12G) and paxillin (data not shown). Note that Src308-GFP was extracted by 
treatment with saponin (Fig. 5H) or digitonin (data not shown), both of which can dissociate proteins from 
cholesterol-rich lipid rafts (85, 86). Furthermore, using fluorescence loss in photobleaching (FLIP) techniques, 
repetitive photobleaching of the perinuclear region completely eliminated Src-GFP fluorescence from the whole 
cell area whereas FLIP did not affect Src308-GFP fluorescence of scattered dots (Fig. S3A-C), suggesting that a 
pool of Src308 that is recruited to focal adhesions and lipid rafts is unable to cycle between PM and LE/Lyso 
probably due to the interaction of the SH2 domain with its binding partners on signaling platforms. Figs. 12E 
and S3D show that the localization and rapid fluorescence recovery of Src(SH4-Unique)-GFP, which lacks the 
SH3, SH2, and kinase domains (Fig. 12A), were similar to those of Src-GFP (Figs. 8A and 9A). In addition, 
Src(SH4-Unique)-GFP was efficiently extracted with TX100 (Fig. 12F). These results therefore suggest that 
cycling c-Src can participate in signaling complexes at focal adhesions and lipid rafts when the SH2 domain 
becomes freely available for protein-protein interactions. 
 
Role of palmitoylation in the localization and trafficking of Lyn  
   It is believed that acylation of the NH2-terminal regions considerably, but not definitely, regulates subcellular 
localizations of SFKs (7, 40, 87). c-Src has only a site for myristoylation, whereas Lyn has sites for both 
myristoylation and palmitoylation (7, 43). Fig. 12E indicates that the NH2-terminal SH4-Unique domain of c-Src 
is an element sufficient for cycling of c-Src between LE/Lyso and PM, suggesting that the distinctive 
localizations between c-Src and Lyn may primarily stem from different lipid modification at their SH4 domains. 
   Fig. 13A shows that fluorescence recovery of perinuclear Lyn-GFP was blocked by treatment with CHX due 
to no inward flow from PM to the Golgi apparatus (Further details are described in 67). To examine whether 
nonpalmitoylation could alter the trafficking pathway of Lyn, we then constructed a nonpalmitoylated Lyn 
mutant, Lyn(C3S)-GFP, which preserves the NH2-terminal myristoylation site. The localization of 
Lyn(C3S)-GFP was similar to that of Lyn(C3S)-HA (Figs. 13B and 15F; data not shown). Strikingly, rapid 
fluorescence recovery of Lyn(C3S)-GFP was observed when perinuclear Lyn(C3S)-GFP was photobleached in 
the presence of CHX (Fig. 13B), similar to that of Src-GFP (Fig. 9A-B). 
   Given that Lyn-GFP localizes to both the Golgi and PM (Fig. S4A; 67), we constructed the deletion mutant 
Lyn(SH4-Unique)-GFP, a counterpart of Src(SH4-Unique)-GFP, to examine the role for the NH2-terminal region 
of Lyn in localization. We found that Lyn(SH4-Unique)-GFP was largely localized to PM (Fig. S4B), whereas 
Lyn∆K-GFP, a counterpart of Src308-GFP, was accumulated at the Golgi (Fig. S4C; 67). These results suggest 
that the primary localization of the palmitoylated NH2-terminal region of Lyn to PM is due to the lack of the SH3 
and SH2 domains. It is intriguing to note the distinctive localizations between Lyn(SH4-Unique)-GFP and 
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Src(SH4-Unique)-GFP (compare Fig. S4B with Figs. 12E and S3D). 
   Furthermore, to examine whether nonpalmitoylated Lyn that is cycling between LE/Lyso and PM could be 
recruited to the signaling platforms, we compared the localization of Lyn∆K-GFP with that of nonpalmitoylated 
Lyn∆K-GFP (Lyn∆K(C3S)-GFP). Unlike Lyn∆K-GFP (Fig. S4C), Lyn∆K(C3S)-GFP was localized 
predominantly to signaling platforms such as focal adhesions and lipid rafts (Figs. 13C, and S4D-E). Therefore, 
these results suggest that nonpalmitoylation drastically changes the trafficking of Lyn from its vectorial, exocytic 
transport to the novel c-Src-type cycling, thereby enabling Lyn to reach signaling platforms at PM. These results 
indicate that the localization and trafficking of nonpalmitoylated Lyn is almost identical to those of c-Src. 
 
c-Yes and Fyn are localized to the Golgi apparatus 
   Next, we examined the localizations of c-Yes and Fyn that are palmitoylated and expressed ubiquitously. 
Like Lyn, c-Yes and Fyn present in the perinuclear region were colocalized with GalT but minimally with Rab7 
(Fig. 14A-C, E, and F). Endogenous Fyn was visible at the Golgi upon observation with high sensitivity of 
fluorescence detection, although overexpressed Fyn did not appear to accumulate at the Golgi apparatus. The 
localization of Fyn-GFP, which preserves the NH2-terminal lipid attachment sites, was similar to that of intact 
Fyn (data not shown). When whole cell area of a Fyn-GFP–transfected cell was photobleached in the presence of 
NEM, recovery of Fyn-GFP fluorescence was observed in both PM and the Golgi (Fig. 14D). These results 
suggest that Fyn not only targets to PM, consistent with previous work (16), but also traffics to PM via the Golgi. 
Although c-Src, Lyn, Fyn, and c-Yes are simultaneously coexpressed in epithelial and fibroblastic cells, the 
trafficking pathways of individual SFKs can be classified into two groups by palmitoylation and 
nonpalmitoylation, implicating their overlapping and specific functions. 
 
Fusion/aggregation of LE/Lyso activated by c-Src or nonpalmitoylated SFKs 
   Rab GTPase proteins function in the tethering/docking of vesicles to their target compartment in the 
secretory and endocytic pathways. Among them, Rab7 and Rab5 are involved in fusion processes of LE/Lyso 
and of EE, respectively (88). To elucidate the role of c-Src present on LE/Lyso, we compared the degree of 
aggregation of Rab7-associated endosomes (Rab7-aggregates), which was driven by active Rab7Q67L due to 
increased membrane fusion (Fig. 15A-C) (68, 89). c-Src and Lyn(C3S)-HA, which cycled between LE/Lyso–PM, 
greatly induced Rab7-aggregates among SFKs cotransfected with GFP-Rab7wt (Fig. 15D-G), whereas Lyn, 
c-Yes and Fyn, all of which trafficked to PM via the Golgi (Fig. 14A-D; 67), showed a marginal effect on the 
induction of Rab7-aggregates (Figs. 14E-F and 15G). 
   Furthermore, no effect of a Src-inhibitor, PP2, on c-Src-induced Rab7-aggregates (Fig. 15H) suggested a 
kinase activity-independent mechanism. To identify a structure responsible for the aggregate induction, we 
constructed various deletion mutants of c-Src (Fig. 15I). Src∆SH2-HA failed to induce Rab7-aggregates (Fig. 
15J) although Src∆SH2-HA was localized to LE/Lyso (Fig. 12C), suggesting the requirement of the SH2 
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domain. Src308 was unable to induce the aggregates despite the fact that the SH2 domain is freely available (Fig. 
12F and G), which may be explained by the localization of Src308 to focal adhesions (Fig. 12F-H). These 
findings suggest that the localization of c-Src to LE/Lyso and the availability of its SH2 domain are 
indispensable for induction of Rab7-aggregates.  
   In contrast, c-Src had no appreciable effect on fusion of Rab5wt-associated EE, which was induced by active 
GFP-Rab5Q79L (Fig. 15K-N) (90, 91). This may be explained by modest colocalization of c-Src with Rab5 or 
by an activation mechanism for Rab7 distinct from that for Rab5. These results implicate the involvement of 
cycling SFKs in biogenesis and maintenance of lysosomes. Assumingly, binding of the SH2 domains of c-Src to 
an unidentified partner that harbors on LE/Lyso may be important for activation of Rab7. 
 
Discussion 
   Here, we demonstrate that c-Src is quite different from Lyn, c-Yes and Fyn in intracellular trafficking. Two 
major distinct pathways are as follows: (i) the LE/Lyso–PM cycling of c-Src, which is not palmitoylated; and (ii) 
the one-way exocytic transport of Lyn, c-Yes and Fyn, which are all palmitoylated, to PM via the Golgi and/or 
directly to PM. Nonpalmitoylation changes the Lyn trafficking from its vectorial transport to the c-Src-type 
cycling. Moreover, we provide evidence that nonpalmitoylated SFKs can control Rab7-mediated vesicle fusion 
events essential for biogenesis and maintenance of the lysosomal compartment in an SH2 domain-dependent 
manner.  
   According to the NH2-terminal sequence, SFKs can be classified as two groups: myristoylated but 
nonpalmitoylated SFKs (c-Src, Blk, and p61Hck) and doubly myristoylated and palmitoylated SFKs (Lyn, c-Yes, 
Fyn, Lck, c-Fgr, and p59Hck) (1, 3, 18, 43).  
   c-Src, Hck, and c-Fgr are coexpressed abundantly in certain hematopoietic cell types, such as osteoclasts. 
Previous reports showed that src-/- mutant mice have a normal number of mature osteoclasts but exhibit 
functional abnormalities in osteoclasts, resulting in impaired bone remodeling and osteopetrosis (92), although 
hck-/- or fgr-/- mutant mice have few and subtle myeloid cell deficiencies (59). Furthermore, src-/-hck-/- double 
mutants develop severe osteopetrosis and consequent hematopoietic defects not seen in the single mutants, 
whereas src-/-fgr-/- double mutants do not develop severe osteopetrosis (60). A combined effect of the src and hck 
mutations implies that c-Src and Hck serve partially overlapping functions but Hck has only a secondary role in 
osteoclasts. In addition, Hck and c-Fgr may be operative in non-overlapping signaling pathways. Taken together 
with the fact that c-Src and p61Hck, unlike c-Fgr, are not palmitoylated (43, 93), we assume that p61Hck as well as 
c-Src is rapidly cycling beween LE/Lyso and PM in osteoclasts. Indeed, Hck strongly correlates with c-Src 
because the level of Hck but not c-Fgr is upregulated in src-/- mutant osteoclasts (60), implicating that c-Src can 
be partially compensated by Hck through a similar cycling pathway in hematopoietic cells coexpressing c-Src 
and Hck. 
    Previous work showed that generation of transgenic mice expressing kinase-deficient SrcK295M in src-/- mice 
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partly rescues impaired osteoclast function (94). A pool of c-Src present in the area of LE/Lyso is shown as 
inactivated c-Src by immunostaining of cells with an anti-phospho-Y416-Src antibody (81). These data support 
our results that Rab7-mediated membrane vesicle fusion is primarily controlled by the SH2 domain of c-Src but 
not kinase activity of c-Src.  
   The small GTPase Ras family are well-known membrane-anchored cytosolic proteins for their 
palmitoylation-regulated intracellular trafficking. H-Ras and N-Ras, which are posttranslationally modified with 
farnesylation and palmitoylation at the C-terminal hypervariable domain, are biosynthetically transported to PM 
through ER/Golgi membranes along the secretory pathway (95). When depalmitoylated, the PM-localized H-Ras 
and N-Ras recycle to the Golgi complex via a nonvesicular exchange between the cytosol and ER/Golgi 
membranes (96). However, our results show that the palmitoylation-regulated trafficking pathways of SFKs are 
distinct from those of Ras proteins. Although palmitoylated SFKs (Lyn, c-Yes and Fyn) are also transported to 
PM along the secretory pathway (Fig. 14; 67), nonpalmitoylated SFKs (c-Src and nonpalmitoylated Lyn mutant) 
cycle between PM and LE/Lyso dependently on vesicle transport that is largely driven by clathrin-mediated 
endocytosis and calcium-independent exocytosis (Figs. 9-11). The difference in palmitoylation-regulated 
intracellular trafficking pathways between Ras and SFKs may be determined by the other lipid modifications, 
such as farnesylation of Ras and myristoylation of SFKs. Nonetheless, palmitoylation is important for not only 
the localization of proteins to membrane microenvironment but also the trafficking.  
   Why are nonpalmitoylated SFKs cycling between LE/Lyso and PM? One possibility is that c-Src functions in 
the regulation of the endocytic and exocytic machinery of endosomes. In particular, c-Src is deeply involved in 
controlling membrane fusion of Rab7-associated vesicles for lysosomal biogenesis (Fig. 15), which may give us 
a clue to account for the functional abnormalities of src-/- and src-/-hck-/- mutant osteoclasts. Another possibility is 
that c-Src awaits activation signals at various locations during the rapid cycling. For instance, activation of c-Src 
at PM leads to its relocalization to signaling platforms such as focal adhesions and lipid rafts (Figs. 12 and 13). 
When activation signals for c-Src are transmitted to early endosomes, RhoD and hDia2C induce a striking 
alignment of early endosomes along actin filaments and reduces their motility (97). Moreover, c-Src activation 
on RhoB-associated LE leads to c-Src translocation from the perinuclear region toward discrete cell peripheral 
structures (81). Conceivably, these possibilities may be mutually inclusive for the basis on c-Src cycling. 
   Palmitoylation may occur at the Golgi and PM after myristoylation, contributing to the exocytotic pathway 
(45). Regulation of palmitoylation, if any, might play a role in selection of the trafficking pathway for SFKs, 
because palmitoylation, in contrast to myristoylation, is known as a reversible lipid modification (43, 98). It 
would be tempting to assume that palmitoylated SFKs to some extent may be depalmitoylated or fail to be 
palmitoylated after biosynthesis under certain conditions. This could release palmitoylated SFKs from the 
secretory pathway. Thus, depalmitoylated or nonpalmitoylated SFKs, despite the palmitoylated type of SFKs, 
might overlap spatially and functionally with nonpalmitoylated SFKs through the cycling pathway. Moreover, 
palmitoylated SFKs are simultaneously accumulated on the Golgi besides PM, implicating that signal 
 27
transduction through SFKs may occur at endomembranes with specific and overlapping functions.  
   Our findings provide a clue to explain an enigma of various subcellular localizations of individual SFK 
members. Multiple combinations in expression of SFKs in a single cell may elaborately serve their specific roles 
and functional compensation through the dynamic cycling and exocytic pathways. Further studies are required to 
determine how palmitoylated or nonpalmitoylated SFKs can distinguish between these different trafficking 
pathways.
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Figure 8. Localization of c-Src to
LE/Lyso. Localizations of c-Src and Lyn.
HeLa cells transfected with c-Src plus GFP-
Rab7wt (A), c-Src (B, C), and Lyn (D), were
doubly visualized with anti-c-Src (red), anti-
Lyn (red), GFP (green), anti-cathepsin D
(green), and anti-GalT (green). All Z-series
sections at 0.5~0.6-mm intervals were merged
in two-dimensional xy images. Orthogonal
sections viewing axial directions (xz and yz)
are created in the margins (A, B). N, nucleus.
Bars, 20 µm.
Figure 9. Rapid cycling of c-Src
between LE/Lyso and PM. FRAP
experiments of Src-GFP in COS-1 cells. (A)
The enclosed area (LE/Lyso; white line) was
photobleached, and the cell was monitored
for the next 10 min at 10-sec intervals. The
magnified images of the square are indicated.
Mean fluorescence intensities in LE/Lyso and
PM are plotted. A representative result is
shown from three independent experiments
(half time for fluorescence recovery in
LE/Lyso t1/2 = 53.5 ± 12.7 (sec), n = 3). (B)
Mean or integrated fluorescence intensities
are plotted in cells treated with CHX. Results
are the mean ± SD from four independent
experiments (t1/2 = 54.9 ± 6.5 (sec), n = 4).
(C) Whole cell area excluding LE/Lyso was
photobleached, and the cell was monitored in
the presence of CHX. Mean fluorescence
intensities in LE/Lyso and PM are plotted,
and results are the mean ± SD from four
independent experiments (half time for
fluorescence recovery in PM t1/2 = 47.9 ±
2.0 (sec), n = 4). N, nucleus; PM, plasma
membrane. Bars, 20 µm.
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Figure 10. Endocytosis of c-Src from PM to LE/Lyso.
(A-E) FRAP experiments of Src-GFP were performed in COS-1 cells in the presence of various inhibitors.
Cells expressing Src-GFP were pretreated with 1mM N-ethyl-maleimide (NEM) for 30 min (A), 5 mM
brefeldin A for 1 h (B), 10 mM nocodazole for 30 min (C), or 0.5 mg/ml cytochalasin D for 30min (D). Cells
expressing Src-GFP were pretreated with hypotonic shock, followed by incubation in the presence (Control)
or absence (K+-depleted) of potassium ion (E). The enclosed area (LE/Lyso) was photobleached, and the cell
was then monitored for the next 10 min at 1-min intervals. Mean fluorescence intensities in LE/Lyso and PM
(A-D) or in LE/Lyso (E) are plotted, and results are the mean ± SD from at least five independent
experiments (no treatment, half time for fluorescence recovery t1/2 = 54.9 ± 7.5 (sec), n = 5, data not shown;
B, t1/2 = 53.0 ± 8.4 (sec), n = 5; C, t1/2 = 47.9 ± 4.3 (sec), n = 6; D, t1/2 = 47.1 ± 2.9 (sec), n = 5). (F)
Coexpression of Src-GFP with AP180-C. COS-1 cells transfected with Src-GFP alone or Src-GFP plus Myc-
AP180-C and COS-1 cells transfected with c-Src alone or c-Src plus Myc-AP180-C were cultured for 24 h,
and doubly visualized by GFP (green), anti-c-Src (green), and anti-Myc (red). Twenty cells showing
relatively strong expression of AP180-C were evaluated for each coexpression experiment. Arrows indicate
the areas of c-Src present in LE/Lyso. The ratios of integrated fluorescence intensity in LE/Lyso (PeriN) to
that in the area excluding LE/Lyso (Non-PeriN) are quantified. Results of Src-GFP and c-Src are the mean ±
SD from three independent experiments and a representative experiment, respectively. LE, late endosomes;
Lyso, lysosomes; N, nucleus; PM, plasma membrane. Bars, 20 µm.
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Figure 11. Calcium-independent exocytosis of c-Src.
FRAP experiments of Src-GFP were performed in COS-1 cells in the
presence of various inhibitors. Whole cell area excluding the enclosed
area (PM) was photobleached, and the cell was then monitored for 5 min.
Cells expressing Src-GFP were pretreated with control medium alone (A),
1 mM NEM for 30 min (B), 5 mM brefeldin A for 1 h (C), 10 mM
nocodazole for 30 min (D), or 10 mM BAPTA-AM for 30 min (E). A
representative result for each inhibitor is shown from three independent
experiments. N, nucleus. Bars, 20 µm
Figure 12. Immobilization of c-Src to focal
adhesions through the SH2 domain.
(A) Schematic representations of GFP-tagged c-Src
mutants used in this study are shown with the Src
homology (SH) domains, the unique domain, the kinase
domain, the negative regulatory tyrosine, and GFP. (B-E)
FRAP experiments of Src308-GFP that lacks the kinase
domain (B), Src308∆SH2-GFP (C), Src308∆SH3-GFP
(D), and Src(SH4-Unique)-GFP that lacks the SH3, SH2
and kinase domains (E) were performed in COS-1 cells.
The enclosed areas in the pre-bleached images were
photobleached, and the cells were then monitored for the
next 10 min at 1-min intervals. Mean fluorescence
intensities in LE/Lyso and PM are plotted (Src308-GFP,
n = 6; Src308∆SH2-GFP, n = 10, half time for
fluorescence recovery in LE/lysosomes t1/2 = 52.1 ± 7.2
(sec); Src308∆SH3-GFP, n = 10; Src(SH4-Unique)-GFP,
n = 12, t1/2 = 43.2 ± 3.5 (sec); Src-GFP, n = 6, t1/2 =
47.2 ± 7.5 (sec), data not shown). (F) Localizations of
GFP-fused Src mutants expressed in living HeLa cells
were visualized before treatment with Triton X-100
(before TX100), and the respective cells were
subsequently in situ extracted with 1% TX100 (after
TX100) at 4 oC for 1 min under a confocal laser
microscope. HeLa cells expressing Src308-GFP (green)
were in situ extracted with 1% TX100 at 4 oC for 1 min
and then stained for vinculin (G, red). (H) HeLa cells
expressing Src308-GFP were in situ extracted with 1%
saponin at 4 oC for 1 min (after Saponin). N, nucleus.
Bars, 20 µm.
Figures 13, 14 
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Figure 13. Role of palmitoylation in Lyn
trafficking.
(A, B) FRAP experiments of Lyn-GFP (A), and
Lyn(C3S)-GFP (B) were performed in COS-1
cells treated with CHX. The enclosed areas
(white line) in the pre-bleached images were
photobleached, and the cells were then monitored
for the next 5 or 10 min at 20-sec intervals. (B)
The magnified images of the square are indicated
in the bottom panels. (C) HeLa cells expressing
Lyn∆K(C3S)-GFP were visualized with GFP
(green) and anti-vinculin (red). N, nucleus. Bars,
20 µm.
Figure 14. Localization of c-Yes
and Fyn to the Golgi apparatus
and PM.
(A-C) HeLa cells transfected with c-Yes
(A), Fyn (B), or none (C) were doubly
visualized with anti-c-Yes (red) or anti-
Fyn (red), and anti-GalT (green). (D)
FRAP experiments of Fyn-GFP were
performed in COS-1 cells. Cells
expressing Fyn-GFP were pretreated
with 1 mM NEM for 30 min. Whole cell
area was photobleached, and the cell
was then monitored for 40 min at 10-
min intervals in the presence of 1 mM
NEM. An arrow and arrowheads
indicate Fyn-GFP accumulated on the
Golgi apparatus and PM, respectively.
(E, F) HeLa cells cotransfected with
GFP-Rab7wt plus c-Yes (E), or with
GFP-Rab7wt plus Fyn (F) were cultured
for 24 h, and doubly visualized with
anti-Yes (red), anti-Fyn (red), or GFP
(green). Endo Fyn, endogenous Fyn; N,
nucleus. Bars, 20 µm.
Figure 15 
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Figure 15. Src-potentiated fusion/aggregation of Rab7-associated endosomes.
(A-J) Increased fusion/aggregation of Rab7-associated endosomes by overexpression of c-Src. HeLa cells transfected
with GFP-Rab7wt (wild-type) (A), GFP-Rab7Q67L (active) (B), GFP-Rab7N125I (dominant-negative) (C), GFP-
Rab7wt plus c-Src (D), GFP-Rab7wt plus Lyn-HA (E), or GFP-Rab7wt plus Lyn(C3S)-HA (F) were cultured for 24 h,
and visualized with anti-Src (red), anti-Lyn (red), and GFP (green). Arrows indicate the perinuclear aggregates of GFP-
Rab7–associated endosomes. The magnified images of the squares are indicated in the insets. N, nucleus. Bars, 20 µm.
(G) HeLa cells transfected with the indicated constructs were cultured for 24 h, or (H) HeLa cells transfected with GFP-
Rab7wt plus c-Src or GFP-Rab7wt alone were cultured for 6 h, and subsequently treated with or without 5 mM PP2 for
12 h. Cells exhibiting the perinuclear aggregates of GFP-Rab7–associated endosomes were quantified, and results are
the mean ± SD from three independent experiments. (I) Schematic representations of Src mutants used in this study are
shown. Src453 and Src308 are kinase-inactive mutants. (J) HeLa cells transfected with the indicated Src mutants were
cultured for 24 h, and cells exhibiting the perinuclear aggregates were quantified. Results are the mean ± SD from four
independent experiments. (K-N) No effect of overexpression of c-Src on fusion/aggregation of Rab5–associated
endosomes. HeLa cells transfected with GFP-Rab5wt (wild-type) (K), GFP-Rab5Q79L (active) (L), GFP-Rab5S34N
(dominant-negative) (M), or GFP-Rab5wt plus c-Src (N) were cultured for 24 h, and visualized with anti-Src (red) and
GFP (green). The magnified images of the squares are indicated in the insets. N, nucleus. Bars, 20 µm.
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Supplemental Figure S1.
Localization of c-Src and Src-
GFP to LE/Lyso.
HeLa cells transfected with c-Src plus
GFP-CD63 (A), c-Src alone (B), Src-
GFP plus HA-Rab7wt (C), and Src-
GFP alone (D) were doubly visualized
with anti-Src (red), GFP (green), anti-
MPR (green), anti-HA (red), and anti-
cathepsin D (red). All Z-series
sections at 0.5-mm intervals were
merged in two-dimensional xy images.
(E) A FRAP experiment of Src-GFP
was performed in COS-1 cells. The
enclosed area in peripheral PM was
photobleached, and the cell was
monitored for the next 5 min at 10-sec
intervals. Mean fluorescence
intensities in the enclosed PM are
plotted. N, nucleus. Bars, 20 µm.
Supplemental Figure S2.
Respective effects of brefeldin A, nocodazole and
cytochalasin D on the Golgi apparatus,
microtubules and F-actin.
HeLa cells treated with 5 mM brefeldin A for 1 h (A), 10 mM
nocodazole (B), and 0.5 mg/ml cytochalasin D (C) for 30 min
were stained with anti-GalT (green), anti-a-tubulin (green), and
rhodamine-phalloidin (red), respectively. Note that the
localization of Src-GFP was not affected by treatment with
brefeldin A under the conditions where GalT was dispersed
from the Golgi apparatus into the ER (See Figures 2 and 3).
Bars, 20 mm.
Supplemental
Figures 3, 4
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Supplemental Figure S3.
Role of the domains of c-Src in
its localization.
FLIP experiments of Src-GFP (A) and
Src308-GFP (B) were performed in
COS-1 cells. The enclosed areas in the
pre-bleached images were repetitively
photobleached for 30 min, and the cells
were monitored in every 5 min. Note
that cells were not treated with CHX.
(C) Mean fluorescence intensities of
Src-GFP and Src308-GFP in PM are
plotted, and results are the mean ± SD
from five independent experiments. (D)
HeLa cells co-transfected with Src(SH4-
Unique)-GFP plus HA-Rab7wt were
cultured for 24 h, and visualized with
GFP (green) and anti-HA (red). Bars, 20
µm.
Supplemental Figure S4.
Localization of Lyn∆K(C3S)-GFP
to focal adhesions and lipid rafts.
(A-C) Localizations of Lyn-GFP
(A), Lyn(SH4-Unique)-GFP (B),
and Lyn∆K-GFP (C) were
visualized in living COS-1 cells
transfected with each construct.
Vertical sections at the lines in
yellow and red are created in the
margins. (D, E) HeLa cells
expressing Lyn∆K(C3S)-GFP were
in situ extracted with 1% TX100
(D, after TX100) or 1% saponin (E,
after Saponin) at 4 oC for 1 min.
The images of Lyn∆K(C3S)-GFP
(D, before TX100; E, before
Saponin) were shown before in situ
extraction. N, nucleus. Bars, 20 µm.
Materials and methods 
Plasmid constructs 
The cDNA for human c-Src (1-536; the number referring to the amino acid position from the initiator 
methionine) (provided by D.J. Fujita; 99) was subcloned into the pcDNA4/TO vector (Invitrogen) by polymerase 
chain reaction using the sense primer 5’-AAAGAATTCCGACCACCATGGGTAGCAA-3’ and the antisense 
primer 5’-TTTCTCGAGCTGTGCCTAGAGGTTCTCCC-3’. Src-GFP (1-532) and Src-HA (1-532) were 
constructed by fusion with GFP obtained from pEGFP-C1 (Clonetech) and by subcloning into the pMH vector 
(Roche) respectively, using appropriate restriction enzymes and blunting. Src453 (1-453; C-terminal kinase 
domain-deleted, kinase-inactive), Src308 (1-308; whole kinase domain-deleted, kinase-inactive), Src308-GFP 
(1-308), Src308∆SH2-GFP (1-184 and 228-308), Src308∆SH3-GFP (1-114 and 141-308), 
Src(SH4-Unique)-GFP (1-65), Src∆SH2-HA (1-184 and 228-532), and Src∆SH3-HA (1-114 and 141-532) were 
generated from c-Src, Src-GFP, and Src-HA, using appropriate restriction enzymes and blunting. Human Lyn 
(provided by T. Yamamoto; 46), Lyn-HA, Lyn∆K (1-298) and Lyn-GFP were as described previously (22, 67). 
The Cys→Ser mutation at position 3 [Lyn(C3S)] was generated by site-directed mutagenesis using the sense 
primer 5’-CACCGCGAGCGGGAAATATGGGATCGATAAAATCAAAAGGG-3’ and the antisense primer 
5’-CCCTTTTGATTTTATCGATCCCATATTTCCCGCTCGCGGTG-3’. The resulting fragments were confirmed 
by sequencing. The cDNAs for human c-Yes (100) and human Fyn (101) subcloned into the pME18SM vector 
were gifted from T. Yamamoto. Fyn-GFP (1-523) was constructed from pME18SM-Fyn (1-536) by fusion with 
GFP using appropriate restriction enzymes and blunting, and was subcloned into the pcDNA4/TO vector. The 
cDNAs for dog Rab7wt (wild-type), Rab7Q67L (active), and Rab7N125I (dominant-negative) subcloned into the 
pEGFP-C1 vector were provided by B. van Deurs (68). HA-Rab7wt was constructed from GFP-Rab7wt by 
subcloned into the pHM/lacZ6 (Roche)-derived vector. The cDNAs for human Rab5awt (wild-type), Rab5aQ79L 
(active), and Rab5aS34N (dominant-negative) subcloned into the pEGFP-C1 vector were provided by B.J. Knoll 
(91). The cDNA for human CD63 (70) subcloned into the pEGFP-C1 vector and the cDNA for N-terminally 
Myc-tagged rat AP180-C (the C-terminus of AP180, amino acids 530 to 915; 78) subcloned into the pCI vector 
(Promega) were gifted by G.M. Griffiths and L. Snyers, respectively. 
 
Antibodies 
Monoclonal anti-Src (clone 327; Oncogene Research Products), anti-Lyn (H-6; Santa Cruz Biotechnology), 
anti-Yes (1B7; Wako Pure Chemicals, Osaka), anti-Fyn (Fyn301; Wako Pure Chemicals, Osaka), and 
anti-vinculin (hVIN-1; Sigma-Aldrich) were used. Affinity-purified rabbit anti-GalT (49) and anti-Myc (A-14, 
Santa Cruz Biotechnology) (provided by M.N. Fukuda), anti-HA (Y-11, Santa Cruz Biotechnology), and 
anti-cathepsin D (DAKO Co.) and anti-cation-independent mannose-6-phosphate receptor (anti-MPR300) 
(provided by Y. Tanaka; 102) were used. FITC- or TRITC-conjugated F(ab’)2 of anti-rabbit IgG and 
TRITC-conjugated anti-mouse IgG were obtained from BioSource International and Sigma-Aldrich. 
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 Cells and transfection 
HeLa cells (Japanese Collection of Research Bioresources) and COS-1 cells were cultured in Iscove’s modified 
DME containing 5% fetal bovine serum. Cells to be examined by fluorescence microscopy were plated at 3 x 104 
per plate into 35-mm dishes containing glass coverslips or 35-mm glass-based dishes, and transiently transfected 
on the next day using the TransIT transfection reagent (Mirus). 
 
Immunofluorescence and live cell imaging 
Immunofluorescence staining was performed as described (49, 50, 52, 55, 67, 103). In brief, cells were washed 
in warmed phosphate-buffered saline (PBS) and fixed in 3% paraformaldehyde for 20 min. Fixed cells were 
permeabilized and blocked in PBS containing 0.1% saponin and 3% bovine serum albumin for 30 min, and then 
incubated with a primary and a secondary antibody for 1 h each. After washing with PBS containing 0.1% 
saponin, cells were mounted onto glass slides and viewed under a Fluoview FV-500 confocal laser scanning 
microscope (Olympus, Tokyo) with a 40x 1.00 NA oil or a 60x 1.00 water-immersion objective. F-actin was 
stained with rhodamine-phalloidin. Fluorescence recovery after photobleaching (FRAP) experiments were 
performed as described (67). If necessary, COS-1 cells were treated with 200 g/ml cycloheximide (CHX) for 3 
hr to inhibit protein synthesis before live cell images were obtained. Fluorescence loss in photobleaching (FLIP) 
experiments were performed using a Fluoview FV500 laser scanning microscope with a 60x 1.00 
water-immersion objective to achieve sufficient depth for bleaching z. The areas enclosed by white circles were 
repetitively photobleached for 30 min at full laser power (100% laser) using the 488 nm line of an argon laser, 
and cells were imaged every 5 min at low laser power (3% laser). Mean and integrated fluorescence intensities 
were quantified using Fluoview Tiempo time course version 4.2 software. Composite figures were prepared 
using Photoshop 5.0 and Illustrator 9.0 software (Adobe). 
 
In situ detergent extraction on a microscopic stage 
After living HeLa cells expressing GFP-fusion proteins were washed twice in ice-cold PBS, fluorescent images 
of a live cell were obtained as “before”. The same cell was subsequently treated in ice-cold PBS containing 1% 
Triton X-100 or 1% saponin for 1 min on a microscopic stage, and fluorescent images were further obtained as 
“after”. 
 
Potassium depletion 
For potassium depletion with hypotonic shock (Hansen et al., 1993), COS-1 cells expressing Src-GFP were 
incubated with serum-free medium at 37 °C for 30 min, followed by exposure to hypotonic medium (diluted 1:1 
with water) for 5 min and isotonic KCl-free buffer for 30 min before live cell images were obtained. As a control, 
COS-1 cells expressing Src-GFP were treated as described above, except for incubation in isotonic 
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KCl-containing buffer. 
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Part III 
Live-cell imaging of biogenesis and trafficking of 
macropinosomes induced by nonpalmitoylated Src-family 
kinases 
 
Abstract 
Src-family kinases, which localize to the cytoplasmic side of cellular membranes through lipid 
modification, play a role in signaling events including membrane trafficking. Macropinocytosis is an 
endocytic process for solute uptake by large vesicles called macropinosomes. Although macropinosomes 
can be visualized by uptake of fluorescent macromolecules, little is known about the dynamics of 
macropinosomes in living cells due to lack of their lifetime markers. Here, we show that expression of 
c-Src constitutively generates macropinosomes in a kinase activity-dependent manner. Live-cell imaging 
with GFP constructs reveals that c-Src associates with macropinosomes throughout their generation at 
membrane ruffles, centripetal trafficking and fusion with late endosomes and lysosomes. Fluorescence 
recovery after photobleaching (FRAP) of Src-GFP shows that macropinosomal membranes are active in 
vesicle transport that mediates the trafficking of c-Src from the plasma membrane and intracellular 
organelles to macropinosomes. Intriguingly, the N-terminal short sequence of c-Src, which confers 
myristoylation but not myristoylation plus palmitoylation, is critical in the association with 
macropinosomes. Furthermore, the tetraspanin CD63 colocalizes with c-Src on macropinosomes, and 
FRAP of GFP-CD63 reaches a plateau with kinetics similar to those of Src-GFP. Our findings indicate 
that c-Src and CD63 are useful markers for macropinosomes, implicating their continued roles in 
macropinocytosis. 
 
 
Introduction 
   Macropinocytosis is an efficient route for non-selective uptake of solute macromolecules including nutrients 
and antigens from extracellular milieu through the formation of clathrin-independent large vesicles in 
heterogenous size (>1 μm in diameter) (104-106). Although high macropinocytic activity is observed in 
phagocytes such as macrophages and dendritic cells, most other cells do not exhibit macropinocytic activity 
under normal culture conditions (104). Some types of cells show remarkable macropinocytosis after stimulation 
with growth factors, such as macrophage colony-stimulating factor (M-CSF) and epidermal growth factor (EGF) 
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(107, 108), and mitogenic agents such as phorbol 13-myristate 12-acetate (PMA) (109, 110). 
   Macropinosomes are generated from sites of membrane ruffling, which can be divided into at least two types: 
cell edge ruffling and dorsal surface ruffling (104, 111, 112). After the formation and subsequent budding, 
macropinosomes mature differently in various cell types. In macrophages, they mature with centripetal 
movement and shrinkage accompanied by changing their compositions: a newly formed macropinosome begins 
as an early endosome derived from the plasma membrane, rapidly matures into a late endosome, and then merges 
with the lysosomal compartment, which is the end point of macropinocytosis (104, 107, 113). Unlike 
macrophages, in EGF-stimulated human epidermoid carcinoma A431 cells macropinosomes are recycled back to 
the cell surface without fusing with lysosomes (108). However, little is known about the difference in the 
macropinosomal maturation processes. 
   Src-family tyrosine kinases (SFKs), which belong to a family of non-receptor-type tyrosine kinases, 
comprise proto-oncogene products and structurally related proteins, and include at least eight members with 
significant amino acid sequence homology (c-Src, Lyn, Fyn, c-Yes, c-Fgr, Hck, Lck, and Blk). SFKs are known 
to play a crucial role in regulating cell proliferation, migration, and cytoskeletal reorganization (1, 3). SFKs have 
been also reported to regulate membrane trafficking, such as endocytic internalization of EGF receptor, early 
endosomal dynamics, and organization of the Golgi apparatus involving protein transport from the Golgi 
apparatus to the ER (66, 97, 114). 
   SFKs are composed of four highly conserved Src homology (SH) domains: an N-terminal SH4 domain, 
followed by a poorly conserved ‘Unique’ domain, an SH3 and an SH2 domain, and an SH1 tyrosine kinase 
domain (1, 3). The SH4 domain contains the signal(s) for acylation such as myristoylation and palmitoylation, 
and regulates an association with the cytoplasmic surface of cellular membranes. The SH3 and SH2 domains can 
mediate protein-protein interactions and the kinase domain catalyzes phosphorylation of the tyrosine residues of 
substrates.  
   Given high homology among the members of SFKs and multiple combinations in their expression, it is of 
little surprise that they can perform overlapping functions. Although mice or cells deficient in multiple members 
of SFKs display more severe defects compared with those deficient in a single SFK member (3, 66, 115), 
specific functions of individual SFKs have been noted with SFK knockout mice or cells (1, 60, 62). However, it 
is obscure how the functional specificity and redundancy of SFKs are regulated. 
   In this study, we show that c-Src, one of the ubiquitously expressed SFKs, induces constitutive 
macropinocytosis in a catalytic activity-dependent manner. SFK-induced macropinocytosis is stringently 
regulated by a state of lipid modification of SFKs, i.e. nonpalmitoylated SFKs, but not palmitoylated SFKs, 
induce macropinocytosis. We further show that live-cell imaging of green fluorescent protein (GFP)-tagged c-Src 
(Src-GFP) enables us to visualize the processes of macropinocytosis because of the continued association of 
Src-GFP with macropinosomes. Moreover, fluorescence recovery after photobleaching (FRAP) techniques 
demonstrate that macropinosomal membranes where c-Src and the tetraspanin CD63 are associated are 
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dynamically active in vesicle transport throughout macropinocytosis. Our findings suggest that c-Src is a useful 
marker for macropinosomes to dissect dynamics of macropinocytosis. 
 
Results 
Expression of c-Src generates large vesicles in the cytoplasm 
   It is often observed that cells expressing c-Src or v-Src can exhibit a number of large vacuole-like structures 
in the cytoplasm (81, 117). To examine the involvement of c-Src in the formation of such vacuolar structures, we 
generated a HeLa cell clone (Src45 cells) that expresses c-Src in an inducible manner. When Src45 cells were 
incubated with doxycycline (Dox, a tetracycline derivative), expression of c-Src was increased and reached a 
steady-state plateau within 3 days (Fig. 16A). On day 1 after induction, Src45 cells were found to contain large 
cytoplasmic vesicles that were visualized with staining of c-Src (Fig. 16B). The number and the size of these 
vesicles were increased in proportion to amounts of autophosphorylated c-Src during 3 days of induction. 
   When COS-1 cells transfected with c-Src and Src-GFP were cultured for 1 day, large cytoplasmic vesicles 
(>1 μm in diameter) were found in 73.2 ± 7.2% of c-Src–expressing cells and 80.6 ± 6.5% of 
Src-GFP–expressing cells (mean ± s.d. from three independent experiments). A Nomarski 
differential-interference-contrast image shows that every large vesicle was associated with Src-GFP (Fig. 16C). 
However, parental COS-1 cells and Src45 cells without Dox barely contained such vesicles that could be 
visualized by Nomarski differential-interference-contrast. These results indicate that the appearance of large 
vesicles is dependent on expression of c-Src. 
   To further examine whether the kinase activity of c-Src was required for the induction of large vesicles, we 
constructed a catalytically inactive, GFP-tagged c-Src mutant, Src516-GFP, by deleting the C-terminal 20 amino 
acid residues of the kinase domain. Src516-GFP is deficient in the activity for tyrosine phosphorylation of 
cellular proteins and autophosphorylation (Fig. 16D), and showed only a marginal effect on the formation of 
large cytoplasmic vesicles (Fig. 16E). Thus, the catalytic activity of c-Src is indispensable for the induction of 
large vesicles. 
 
c-Src–induced, large cytoplasmic vesicles are defined as macropinosomes 
   To characterize the large vesicles that were induced by the kinase activity of c-Src, we examined whether 
those vesicles were involved in solute endocytosis. Fig. 17A shows that c-Src–induced large vesicles were 
capable of taking up RITC-conjugated dextran (~70 kDa) from the culture medium. The formation of large 
vesicles was unaffected by expression of dominant-negative AP180-C (the clathrin-binding C-terminal domain 
of AP180; 78) (Fig. 17B), suggesting that the large vesicles are generated in a clathrin-independent endocytic 
manner. We then examined whether the large vesicles were associated with macropinosomal proteins by double 
staining of COS-1 cells expressing c-Src or Src-GFP. Fig. 17C and D shows that c-Src anchored on 
c-Src–induced large vesicles at membrane ruffles was colocalized with Rab34 and annexin II, which were 
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reported as macropinosomal proteins found on an early-phase subset of macropinosomes (110, 118). 
Furthermore, to some extent c-Src–induced large vesicles were associated with Rab5 (a marker for early 
endosomes; 68) or Rab7 (a marker for late endosomes and lysosomes; 91) (Fig. 17E and F). A fraction of 
cathepsin D (a lysosomal protease) was seen in the large vesicles (Fig. 17G). However, they were not associated 
with β-1,4-galactosyltransferase (GalT, a trans-Golgi resident protein) and cation-independent mannose 
6-phosphate receptor (MPR, a trans-Golgi network-enriched protein) (Fig. 17H and I). These results are 
consistent with previous reports that macropinosomes change from early-endosome-like organelles to 
late-endosome-like organelles and then fuse with lysosomes without routing through the Golgi apparatus during 
the maturation process (104, 107). Note that most of the large vesicles were associated with the tetraspanin 
CD63 (a lysosome–plasma membrane cycling protein; 69, 70) (Fig. 17J). Moreover, formation of large vesicles 
was not observed in the presence of wortmannin (a PI3-K inhibitor) upon our time-lapse monitoring of COS-1 
cells expressing Src-GFP (data not shown), consistent with previous observations of the involvement of PI3-K in 
macropinosome biogenesis (111, 119). Thus, these results indicate that the large vesicles induced by the kinase 
activity of c-Src are considered as bona fide macropinosomes. 
 
c-Src–induced macropinosomes are visualized with Src-GFP 
   It is likely that c-Src is a marker protein for macropinosomes throughout macropinocytosis. To examine the 
process of macropinosome formation induced by expression of c-Src, we took advantage of visualization of 
macropinosomes in living cells by fluorescence of Src-GFP (Fig. 16C). Indeed, time-lapse monitoring of living 
cells expressing Src-GFP enabled us to pursue detailed processes of formation and subsequent behaviors of 
macropinosomes. Fig. 18A and B shows that macropinosomes were rapidly generated at peripheral membrane 
ruffles, sometimes at dorsal surface ruffles, and then migrated centripetally while shrinking. Occasionally, these 
macropinosomes fused with each other or vanished (Fig. 18C and D). Thus, these results indicate that 
macropinosomes, whose morphology was depicted in previous reports (104, 108), is constitutively generated by 
expression of c-Src from membrane ruffles at the cell edge and the perinuclear dorsal surface. 
   Since macropinocytosis is accompanied by rigorous membrane ruffling and fusion, we assumed that 
macropinosomal membranes might furnish an active platform for dynamic protein trafficking. To examine 
whether c-Src was mobile from intracellular membranes to macropinosomes, we used fluorescence recovery 
after photobleaching (FRAP) techniques on Src-GFP–labeled macropinosomes. COS-1 cells transfected with 
Src-GFP were pretreated with cycloheximide, an inhibitor of protein synthesis. When the area of 
macropinosomes in Src-GFP–transfected cells was photobleached in the presence of cycloheximide, rapid 
fluorescence recovery of Src-GFP on macropinosomes was observed and reached a steady-state plateau (Fig. 
19A). To exclude the possibility that the fluorescence recovery was mediated by lateral diffusion from the 
plasma membrane or free exchange between macropinosomes and the cytosol, we used N-ethyl-maleimide 
(NEM), a reagent known to block a wide range of vesicle fusion events (27). Fig. 19B shows that fluorescence 
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recovery of Src-GFP was blocked by treatment with NEM, suggesting that mobilization of c-Src to 
macropinosomes is definitely mediated by membrane vesicle transport. We then examined whether the 
mobilization of c-Src was dependent on vesicle shuttling between macropinosomes and intracellular organelles. 
Fig. 19C and D shows that the fluorescence recovery of Src-GFP on macropinosomes was partly inhibited in the 
presence of tannic acid (TA), a cell-impermeable fixative known to prevent membrane fusion at the plasma 
membrane but not to affect intracellular membrane trafficking (120). These results suggest that c-Src can traffic 
to macropinosomes from the plasma membrane and intracellular organelles through vesicle transport. 
 
c-Src–induced macropinosomes are visualized with GFP-CD63  
   As shown in Fig. 17J, the tetraspanin CD63 featuring four transmembrane domains was found to well 
colocalize with c-Src on c-Src–induced macropinosomes, suggesting that CD63 is another marker for 
macropinosomes. However, unlike c-Src, expression of CD63 alone could not induce macropinosome formation 
(Fig. 20A). Accordingly, we attempted to cotransfect COS-1 cells with c-Src and GFP-CD63 to generate 
macropinosomes and visualize them in living cells by fluorescence of GFP-CD63. When macropinosomal 
GFP-CD63 was photobleached in the presence of cycloheximide, rapid fluorescence recovery of GFP-CD63 
reached a steady-state plateau with kinetics similar to those of Src-GFP (compare Fig. 20E and F with Fig. 
19D). Note that the rates of fluorescence recovery of GFP-CD63 on peripheral macropinosomes were almost 
identical to those on perinuclear macropinosomes. These results indicate that CD63 rapidly traffics to 
macropinosomes from the plasma membrane and intracellular organelles such as lysosomes and late endosomes, 
suggesting that macropinosomal membranes are dynamically active throughout their migration away from the 
cell edge toward the nucleus. 
 
Nonpalmitoylated SFKs can stimulate macropinocytosis 
   Next, we examined whether other ubiquitously expressed SFKs, such as Fyn and Lyn, were involved in 
macropinocytosis. While COS-1 cells transfected with Fyn-GFP or Lyn-GFP were cultured for 1 day, 
macropinosomes were barely detected by fluorescence microscopy or Nomarski optics (Fig. 21A, B, and D). 
Assumingly, the difference in the N-terminal lipid modification of SFKs may be important for stimulation of 
macropinocytosis, because c-Src has only a site for myristoylation whereas Fyn and Lyn have sites for 
myristoylation and palmitoylation (8, 43). We then constructed Lyn(C3S)-GFP, a GFP-tagged nonpalmitoylated 
Lyn mutant, and found that expression of Lyn(C3S)-GFP stimulated macropinocytosis in a manner that 
expression of Src-GFP did (Fig. 21C and D). These results demonstrate that nonpalmitoytion of SFKs is 
required for stimulation of maropinocytosis. 
 
The N-terminal region of c-Src is a useful marker for macropinosomes 
   Although macropinosomes can be visualized in cells by uptake of fluorescent water-soluble substances such 
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as RITC-dextran (Fig. 17A), thus far an appropriate marker protein that is continuously associated with 
macropinosomes has not yet been defined. Our findings described above suggest that c-Src and CD63 are new 
marker proteins for macropinosomes. Note that expression of CD63 did not induce macropinosome formation 
(Fig. 20A), although CD63 is reported to interact with integrins and modulate cell adhesion (121, 122). However, 
c-Src per se has the strong ability to stimulate constitutive macropinocytosis by means of its catalytic activity 
(Fig. 16). Thus, c-Src and CD63 may not be infallible macropinosomal markers. 
   To overcome these problems, we attempted to create a biologically inactive structure that is sufficient for a 
continued association with macropinosomes. We deleted most of the functional domains of c-Src, and produced 
the NH2-terminal sequence (1-65 amino acid residues) of c-Src tagged with GFP [Src(SH4-Unique)-GFP] that 
preserves the NH2-terminal myristoylation site but lacks the SH3, SH2 and kinase domains. Fig. 22A shows that 
expression of Src(SH4-Unique)-GFP did not induce macropinosome formation. We then investigated whether 
Src(SH4-Unique)-GFP could be continuously associated with macropinosomes as a suitable marker. Treatment 
of mouse C3H/10T1/2 fibroblasts (10T1/2 cells) with phorbol myristate acetate (PMA) stimulated 
macropinocytosis (110), whereas expression of Src(SH4-Unique)-GFP alone in 10T1/2 cells did not induce 
macropinosome formation under unstimulated conditions (Fig. 22B). When 10T1/2 cells transfected with 
Src(SH4-Unique)-GFP were treated with PMA, formation of macropinosomes at membrane ruffles and their 
migration toward the nucleus were clearly visualized by fluorescence of Src(SH4-Unique)-GFP (Fig. 22C). 
These results indicate that the N-terminal short sequence of c-Src is sufficient for the association with 
macropinosomes, and that Src(SH4-Unique)-GFP is a useful marker for macropinosomes in living cells. 
 
Discussion 
   In the present study, we showed that the generation and subsequent migration of macropinosomes can be 
continuously visualized by fluorescence of Src-GFP in living cells. FRAP analyses revealed that 
macropinosomal membranes are dynamically active in vesicle transport that mediates the trafficking of c-Src and 
CD63 from the plasma membrane and intracellular organelles to macropinosomes throughout migration of 
macropinosomes from the ruffling cell edge toward the inside of cells. 
 
Macropinocytosis induced by the kinase activity of c-Src 
   We showed that inducible or transient expression of c-Src triggers the formation of large vacuolar structures 
in the cytoplasm, as has been often seen in cells expressing c-Src or v-Src (81, 117). Such Src-induced large 
vesicles were identified as bona fide macropinosomes in the light of the following characteristics of the vesicles 
(Figs. 16-18): (1) the morphology that is accompanied by membrane ruffling (104, 109, 123), (2) the 
immunostaining with macropinosome-associated proteins as described previously (107, 110, 118), (3) the uptake 
of extracellular fluorescent dextran (81, 108, 110, 124), and (4) the clathrin-independent formation (113, 125). 
   Previous studies suggested that the pathway from the activated oncogenes v-Src and K-Ras to 
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macropinocytosis in oncogenically transformed fibroblasts depends on sequential permanent activation of 
phosphoinositide 3-kinase and phospholipase C, leading to constitutive ruffling and macropinocytosis through 
reorganization of the actin cytoskeleton (119, 126-129). Our findings provide further evidence that a high level 
of the kinase activity of c-Src, but not long-term oncogenic transformation, is sufficient for induction of 
constitutive macropinosomes (Fig. 16). 
 
c-Src as a marker for macropinosomes throughout their lifetime 
   In higher eukaryotes, constitutive macropinocytosis is typically restricted to specialized conditions such as 
immature dendritic cells (130) activated macrophages (123) or transformed cells (128-130). In most other cells, 
macropinocytosis can be transiently induced by growth factors, PMA and diacylglycerol, as well as by some 
invasive bacteria (108, 109, 131-133). Although macropinosomes together with other types of endocytic vesicles 
were visualized by non-selective uptake of extracellular solutes such as RITC-dextran (see Fig. 17A), little 
progress has been made in determining the mechanisms that regulate the generation and migration of 
macropinosomes due to lack of an accurate assessment of macropinosomes. 
   In this study, we demonstrated that c-Src is continuously associated with macropinosomes from their 
generation at sites of membrane ruffling to their fusion with late endosomes and lysosomes (Figs. 16-18). We 
further showed that the N-terminal short sequence of c-Src, which lacks the major protein-interacting domains, is 
sufficient for its continued labeling of macropinosomes, and that expression of Src(SH4-Unique)-GFP enables us 
to visualize the dynamics of macropinocytosis induced by PMA in living cells (Fig. 22). In addition, we showed 
that the tetraspanin CD63 may be another marker for macropinosomes in their lifetime (Figs. 17J and 20) 
despite its latent modulation of cell adhesion (122). 
   Although it is hypothesized that macropinosomes may acquire lysosomal membrane proteins before 
completion of fusion with lysosomes and regurgitate them to the plasma membrane by shuttling of small vesicles 
(104, 107, 109), this remained to be verified due to lack of a suitable marker for macropinosomes. By FRAP of 
Src-GFP– or GFP-CD63–labeled macropinosomes, we provide evidence for the existence of vesicle transport 
from the plasma membrane and intracellular organelles to macropinosomes. When photobleached, fluorescence 
of Src-GFP on macropinosomes was rapidly recovered (Fig. 19). We also found kinetics of fluorescence 
recovery of GFP-CD63 similar to those of Src-GFP (Fig. 20). Furthermore, the fluorescence recovery of 
Src-GFP on macropinosomes was completely inhibited by treatment with NEM and partly by treatment with 
tannic acid (Fig. 19B-D), suggesting rapid exchange of macropinosomal membranes with the plasma membrane 
and other organelle membranes by means of membrane vesicle shuttling. These results suggest that time-lapse 
monitoring combined with photobleaching techniques using Src-GFP or GFP-CD63 may be a useful approach 
for further investigation of macropinocytosis in living cells. In addition, the findings of the mobilization of CD63, 
similar to that of c-Src, may support a functional role for CD63 in macropinocytosis. 
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Role of palmitoylation of SFKs in induction of macropinocytosis 
   We showed that c-Src, a nonpalmitoylated SFK, induces constitutive macropinocytosis in a kinase 
activity-dependent manner and is associated with macropinosomes during the entire process of macropinocytosis 
(Figs. 16-18). However, Lyn and Fyn, both of which are palmitoylated SFKs, had no appreciable effect on the 
induction of macropinocytosis (Fig. 21). Intriguingly, we found that Lyn(C3S)-GFP, a nonpalmitoylated Lyn 
mutant, is capable of inducing macropinocytosis (Fig. 21).  
   Macropinocytosis (fluid uptake) and phagocytosis (particle uptake) are clathrin-independent processes that 
result in the formation of fluid-filled macropinosomes (>1 μm in diameter) and particle-containing phagosomes 
(>0.5 μm in diameter), respectively (105). Macropinocytosis appears, at least superficially, comparable to 
phagocytosis in term of pseudopod extension and an actin-dependent process (105, 134, 135). Macropinosomes 
and phagosomes follow the same endocytic pathway, and a number of proteins are identified that associate with 
both macropinosomes and phagosomes (107, 118, 124, 135, 136). Despite the similarity between them, recent 
evidence has suggested that macropinocytosis and phagocytosis are biochemically distinct (105, 137). 
   Recent findings showed that inhibition of Fc receptor-mediated phagocytosis in macrophages by 
overexpression of Csk, which suppresses the catalytic activity of SFKs, is rescued by expression of kinase-active 
Lyn and kinase-active p59Hck, the palmitoylated isoform of Hck, but not by expression of kinase-active c-Src 
(138). Taken together with our results, these data suggest that SFKs can stimulate two similar, but biochemically 
distinct, endocytic pathways in a way that nonpalmitoylated and palmitoylated SFKs may be involved in 
macropinocytosis and phagocytosis, respectively. 
   Why is phagocytosis but not macropinocytosis thought to be regulated by palmitoylated SFKs? 
Palmitoylation is postulated to regulate the signaling pathways via SFKs by modulating their intracellular 
localization to the membrane microenvironment (43, 45). It is suggested that Fc receptor-mediated 
phagocytosis is stimulated by palmitoylated SFKs, which are associated with the detergent-resistant membranes 
(DRM), but not by c-Src that is excluded from the DRM (138), because the tyrosine phosphorylation of Fc 
receptor and the subsequent signaling controlled by SFKs are predominantly performed at the DRM and the 
accessibility of SFKs to the DRM is dependent on their palmitoylation (43, 45, 139, 140).  
   Recently we reported that Lyn is biosynthetically transported to the plasma membrane via the Golgi 
apparatus along the secretory pathway (67). Lck, one of the palmitoylated SFKs, was also reported to follow the 
secretory pathway (17, 45). In sharp contrast to Lyn and Lck, c-Src and p61Hck, both of which are 
nonpalmitoylated SFKs, are localized to late endosomes and lysosomes, and are transported to the plasma 
membrane from these organelles (81, 141; our unpublished data). Moreover, p61Hck, but not p59Hck, triggers the 
biogenesis of podosomes, the actin-rich rings at the ventral cell surface, by exocytosis from lysosomes (141). 
These results implicate that c-Src and p61Hck may be involved in the biogenesis of lysosome-related membrane 
vesicles such as macropinosomes and podosomes through a specific intracellular trafficking pathway for 
nonpalmitoylated SFKs. Further studies will be required to understand a key mechanism for the regulation of 
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macropinocytosis by nonpalmitoylated SFKs. 
 
Possible functions of c-Src for macropinosomal maturation 
   It has been reported that, in EGF-stimulated A431 cells and aluminum fluoride-treated HeLa cells 
overexpressing Arf-6, newly formed macropinosomes remain in the peripheral cytoplasm where membrane 
ruffling occurs and go back to the cell surface without fusing with other organelles such as endosomes and 
lysosomes (104, 108, 142). In contrast, we found that macropinosomes induced by expression of c-Src can move 
centripetally and fuse with lysosomes (Figs. 17 and 18), as can be seen in M-CSF–stimulated macrophages 
(107). c-Src may therefore play a role for both formation and maturation of macropinosomes, because c-Src is 
associated with macropinosomes throughout their lifetime after budding at the plasma membrane. 
   The regulation of phagosomal maturation has been largely ascertained by isolation of latex bead-containing 
phagosomes and suchlike (135, 136, 143, 144), whereas the molecular steps regulating macropinocytosis remain 
elusive due to lack of suitable marker proteins and macropinosomal isolation methods. Recent studies indicated 
that a number of the substrates and/or binding proteins of SFKs, such as annexin II and PI3-K, are associated 
with macropinosomes and phagosomes (129). A different set of proteins is phosphorylated and dephosphorylated 
at precise intervals during phagosomal maturation (143). In addition, Rab5 and Rab7, the major macropinosomal 
components, are activated by v-Src through an unknown mechanism (117). The membrane-cytoskeleton 
interactions underlying organelle positioning and motility are regulated by Rho-Dia-Src signaling cascades (97). 
Taken together, these results implicate that c-Src is involved in maturation besides formation of macropinosomes. 
Thus, it would be of interest to dissect the dynamics of generation and trafficking of macropinosomes in living 
cells by using Src(SH4-Unique)-GFP. 
 
Conclusion 
   It is clear from this work that Src strongly induces constitutive macropinocytosis in a manner dependent on 
the kinase activity and nonpalmitoylation of SFKs. Furthermore, the processes of macropinocytosis and rapid 
vesicle transport on macropinosomes are dynamically visualized in living cells by time-lapse monitoring and 
FRAP using Src-GFP. We also demonstrate that Src-GFP, Src(SH4-Unique)-GFP, and CD63 are useful markers 
for macropinosomes. Further studies using this approach are expected to reveal the molecular steps regulating 
macropinocytosis in living cells. 
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Figure 16 
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Figure 16. Formation of large vesicles induced by expression of c-Src.
(A) HeLa cells inducibly expressing c-Src (Src45 cells) were cultured in the presence of doxycycline (Dox) for the
indicated periods. Western blots of equal amounts of Triton X-100 lysates were probed with anti-phosphotyrosine (pTyr),
and subsequently reprobed with anti-c-Src and anti-actin. An arrow indicates autophosphorylated c-Src. (B) Src45 cells
were cultured in the presence of Dox for 1 or 3 days, and stained with anti-c-Src. Arrows indicate large vesicles that are
associated with c-Src. (C) COS-1 cells transiently transfected with Src-GFP were cultured for 1 day, and live cells were
imaged by GFP fluorescence and Nomarski differential-interference-contrast. One planar (xy) section slice is shown (a).
The magnified images of lower (b) and upper (c) sections of the squared area are shown and orthogonal sections viewing
axial direction (xz and yz) are created in the margins (b, c). Note that large vesicles associated with Src-GFP were clearly
visualized by Nomarski differential-interference-contrast. N, nucleus. Bars, 5 µm. (D) Western blots of equal amounts of
Triton X-100 lysates from COS-1 cells transiently transfected with none, Src-GFP or Src516-GFP were probed with anti-
pTyr, and subsequently reprobed with anti-c-Src. An arrow indicates autophosphorylated Src-GFP. (E) COS-1 cells
transiently transfected with Src-GFP or Src516-GFP were cultured for 1 day, and cells exhibiting ≥1 large vesicles (>2
µm in diameter) were quantified. Results are the mean ± s.d. from three independent experiments.
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Figure 17. c-Src–induced large vesicles defined as macropinosomes.
(A) COS-1 cells transiently transfected with Src-GFP were cultured for 1 day in the presence of 1 mg/ml
RITC-dextran (Mr 70,000) during the last 3 hours, and Src-GFP and dextran were doubly visualized by GFP
(green) and RITC fluorescence (red). Arrows indicate c-Src–associated large vesicles where RITC-dextran
was taken up. N, nucleus. Bars, 5 µm. (B) COS-1 cells transiently transfected with Src-GFP plus myc-AP180-
C were cultured for 1 day, and Src-GFP and AP180-C were doubly visualized by GFP fluorescence (green, a-
c) and anti-myc (red, d). The squared areas are magnified (b, c). Arrows indicate c-Src–associated large
vesicles. N, nucleus. Bars, 5 µm. (C-J) COS-1 cells transiently transfected with c-Src plus GFP-Rab34 (C),
Src-GFP alone (D, G-I), c-Src plus GFP-Rab5 (E), c-Src plus GFP-Rab7 (F) and c-Src plus GFP-CD63 (J)
were cultured for 1 day, and expressed proteins were visualized by GFP fluorescence (green), anti-c-Src (red,
C, E, F and J), anti-annexin II (red, D), anti-cathepsin D (red, G), anti-galactosyltransferase (GalT; red, H)
and anti-mannose-6-phosphate receptor (MPR; red, I). All Z-series sections at 0.5-µm intervals were merged
in two-dimensional xy images. Arrowheads indicate the colocalization of c-Src with Rab34 or annexin II at
membrane ruffles. The magnified images of the squared areas are shown in insets. N, nucleus. Bars, 20 µm.
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Figure 18. Time-lapse
monitoring of macropinosome
biogenesis and trafficking in
living cells upon expression of
Src-GFP.
Biogenesis of macropinosomes
from peripheral ruffles (A) and
dorsal-surface ruffles (B) was
monitored by GFP fluorescence
at 5-second intervals in living
COS-1 cells expressing Src-GFP.
A starting point of time-lapse
monitoring is indicated as 0
second (00ʼ00”). White and red
arrows indicate macropinosomes
that were already formed at the
starting point of monitoring and
those that were newly formed
during a monitoring period,
respectively. The magnified
images of the square are
indicated on the right (B). Note
that Src-GFP–associated
macropinosomes were rapidly
formed from membrane ruffles,
and then moved centripetally at a
slow speed with a decrease in the
size of macropinosomes. COS-1
cells expressing Src-GFP were
monitored by GFP fluorescence
at 5-second (C) or 10-second
intervals (D). Starting points of
time-lapse monitoring are
indicated as 0 second (00ʼ00”).
(C) Two macropinosomes moved
centripetally at a slow speed
(00ʼ00”-13ʼ25”), and were then
fused (13ʼ30”-13ʼ45”). The
magnified images of the squared
area are aligned on the right. (D)
One of the two macropinosomes
(designated as α and β)
disappeared while shrinking (a).
Mean fluorescence intensities of
these macropinosomes are shown
(b). Note that the disappearing
macropinosome (α was not
absorbed by the other) . N,
nucleus. Bars, 5 µm.
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Figure 19. FRAP of Src-GFP on
macropinosomes.
FRAP experiments of Src-GFP were
performed in COS-1 cells treated with 200
µM cycloheximide. Cells expressing Src-
GFP were pretreated with none (A), 1 mM
NEM (B), or 0.5% tannic acid (C) for 10
minutes. The enclosed areas (yellow circles)
were photobleached, and then the cells were
monitored at 5-second (A, C) or 60-second
intervals (B) for 10 minutes. (D) Mean
fluorescence intensities on macropinosomes
are measured, and results are the mean ±
s.d. (Control, n = 4; NEM, n = 3; Tannic
acid, n = 5). N, nucleus. Bars, 5 µm.
Figure 20. FRAP of GFP-CD63 on
c-Src–induced macropinosomes.
COS-1 cells transiently transfected with
GFP-CD63 (A) and GFP-CD63 plus c-Src
(B) were cultured for 1 day, and expressed
proteins were visualized by GFP
fluorescence (green) and anti-c-Src (red, B).
Arrows indicate macropinosomes that are
associated with CD63 and c-Src. FRAP
experiments of GFP-CD63 were performed
in COS-1 cells expressing GFP-CD63 plus
c-Src that were treated with 200 µM
cycloheximide. The enclosed areas on
macropinosomes appearing at the peripheral
(C, E) and perinuclear (D, F) regions were
photobleached, and then the cells were
monitored at 5-second intervals for 10
minutes. Mean fluorescence intensities on
macropinosomes were measured, and
representative results are shown in panels E
and F. Note that the kinetics in fluorescence
recovery of GFP-CD63 on peripheral and
perinuclear macropinosomes are similar to
that of Src-GFP (see Fig. 4D, Control). N,
nucleus. Bars, 5 µm.
Figures 21, 22
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Figure 21. Induction of
macropinocytosis by Src-family
kinases that are not
palmitoylated.
COS-1 cells transiently transfected
with Fyn-GFP (A), Lyn-GFP (B), and
Lyn (C3S)-GFP (C) were cultured for 1
day, and macropinosomes were
visualized by GFP fluorescence and
Nomarski differential-interefence-
contrast. (D) COS-1 cells transiently
transfected with the indicated SFKs
were cultured for 1 day, and cells
exhibiting ≥1 macropinosomes (>2 µm
in diameter) were quantified. Results
are the mean ± s.d. from three
independent experiments. N, nucleus.
Bars, 20 µm.
Figure 22. Src(SH4-Unique)-GFP
as a useful marker for
macropinosomes.
(A) COS-1 cells transiently transfected
with Src(SH4-Unique)-GFP were
cultured for 1 day, and cells exhibiting
≥1 macropinosomes (>2 µm in
diameter) were quantified. Results are
the mean ± s.d. from three independent
experiments. For comparison, the open
bar is a reproduction of the Src-GFP
data of Fig. 16E. (B) C3H/10T1/2 cells
transiently transfected with Src(SH4-
Unique)-GFP were imaged by GFP
fluorescence and Nomarski
differential-interference-contrast. (C)
C3H/10T1/2 cells transiently
transfected with Src(SH4-Unique)-GFP
were treated with 200 nM PMA, and
the cell was monitored at 30-second
intervals. The time at the addition of
PMA is indicated as 0 second (00ʼ00”).
Arrows indicate macropinosomes. N,
nucleus. Bars, 20 µm.
Materials and Methods 
Plasmid constructs 
The cDNA for human c-Src (1-536; the number referring to the amino acid position from the initiator 
methionine) (kindly provided by D.J. Fujita; 99) was subcloned into the pcDNA4/TO vector (Invitrogen) by 
polymerase chain reaction (PCR) using the sense primer 5’-AAAGAATTCCGACCACCATGGGTAGCAA-3’ 
and the antisense primer 5’-TTTCTCGAGCTGTGCCTAGAGGTTCTCCC-3’. Src-GFP (1-532) was 
constructed by fusion with GFP obtained from pEGFP-C1 (Clonetech Laboratories) using appropriate restriction 
enzymes. Src516-GFP (1-516) and Src(SH4-Unique)-GFP (1-65) were generated from Src-GFP using 
appropriate restriction enzymes and blunting. Human Lyn (kindly provided by T. Yamamoto; 46) and Lyn-GFP 
were described previously (67). The Cys→Ser mutation at position 3 [Lyn(C3S)] was generated by site-directed 
mutagenesis using the sense primer 5’-CACCGCGAGCGGGAAATATGGGATCGATAAAATCAAAAGGG-3’ 
and the antisense primer 5’-CCCTTTTGATTTTATCGATCCCATATTTCCCGCTCGCGGTG-3’. The resulting 
fragments were all confirmed by sequencing. Fyn-GFP (1-523) was constructed from cDNA for human Fyn 
(1-536) (kindly gifted from T. Yamamoto; 101) by fusion with GFP using appropriate restriction enzymes and 
blunting, and was subcloned into the pcDNA4/TO vector. GFP-tagged mouse Rab34 were constructed as 
described previously (110). The cDNAs for dog Rab7 (68), human Rab5a (91) and human CD63 (70) subcloned 
into the pEGFP-C1 vector were provided by B. van Deurs, B.J. Knoll and G.M. Griffiths, respectively. The 
cDNA for N-terminally myc-tagged rat AP180-C (the C-terminus of AP180, amino acids 530 to 915; 78) 
subcloned into the pCI vector (Promega) was gifted by L. Snyers. 
 
Antibodies and reagents 
Monoclonal anti-Src (clone 327; Oncogene Research Products), anti-phosphotyrosine (anti-pTyr, 4G10; Upstate 
Biotechnology, Inc.), anti-annexin II (Transduction Laboratories) and anti-actin (MAB1501; CHEMICON 
international Inc.) were used. Affinity-purified rabbit anti-galactosyltransferase (GalT) (49), anti-myc (A-14, 
Santa Cruz Biotechnology) (provided by M.N. Fukuda), anti-cathepsin D (DAKO Co.) and 
anti-cation-dependent mannose 6-phosphate receptor (MPR) (102) (kindly provided by Y. Tanaka) were used. 
Horseradish peroxidase (HRP)-conjugated F(ab’)2 of antibody to mouse IgG was purchased from Amersham 
Biosciences. TRITC-F(ab’)2 of anti-rabbit IgG and TRITC-anti-mouse IgG were obtained from BioSource 
International and Sigma-Aldrich. N-ethylmaleimide (NEM) and tannic acid were obtained from Wako Pure 
Chemicals (Osaka, Japan). Rhodamine B isothiocyanate (RITC)-dextran (Mr 70,000), phorbol 13-myristate 
12-acetate (PMA), cycloheximide and wortmannin were from Sigma-Aldrich. 
 
Cells and transfection 
COS-1 cells, HeLa cells (Japanese Collection of Research Bioresources) and mouse C3H/10T1/2 (10T1/2) 
fibroblasts (110) were cultured in Iscove’s modified DME containing 5% fetal bovine serum (FBS). Transient 
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transfection was performed using TransIT transfection reagent (Mirus), according to the manufacture’s 
instructions, as reported (67, 103).  
 
Src45 cell line 
The CAG promoter-controlled pCAG-TR vector that expresses tetracycline repressor (TR) was constructed from 
the CMV promotor-controlled pcDNA6/TR (Invitrogen) by subcloning into the pCAG vector (provided by J. 
Miyazaki; 48) to increase the expression level of tetracycline repressor. A HeLa cell clone stably transfected with 
pCAG-TR (clone 3-2) was selected in Iscove’s modified DME containing 5% FBS and 200 μg/ml hygromycin B 
(Wako Pure Chemicals, Osaka, Japan) by cotransfection with a plasmid encoding the hygromycin-resistance 
gene. The expression level of TR in the clone 3-2 was approximately eight-fold higher than that in 
T-RExTM–HeLa cells (Invitrogen), when examined by western blotting using anti-TR (Invitrogen) (data not 
shown). The Src45 cell line was generated from the clone 3-2 by stable transfection with the pcDNA4/TO vector 
(Invitrogen) encoding c-Src and subsequent selection in the medium containing 5% FBS and 333 μg/ml Zeocin 
(Invitrogen). Doxycycline, a derivative of tetracycline, was used at 2 μg/ml for induction of c-Src.  
 
Immunofluorescence 
Immunofluorescence staining was performed as described (49, 52, 55, 67). In brief, cells were washed in 
warmed phosphate-buffered saline (PBS) and subsequently fixed in 3% paraformaldehyde for 20 minutes. For 
annexin II staining, cells were fixed in 100% methanol at –30°C for 1 minute after removal of the medium. 
Fixed cells were permeabilized and blocked in PBS containing 0.1% saponin and 3% bovine serum albumin 
(BSA) for 30 minutes, and then incubated with a primary and a secondary antibody for 1 hour each. After 
washing with PBS containing 0.1% saponin, cells were mounted onto glass slides with ProLong antifade reagent 
(Molecular Probes) and viewed under a Fluoview FV500 confocal laser scanning microscope (Olympus, Tokyo) 
with a 40x 1.00 NA oil or a 60x 1.00 water-immersion objective. Composite figures were prepared using 
Photoshop 5.0 and Illustrator 9.0 software (Adobe). 
 
Live-cell imaging 
For live-cell imaging, cells cultured in 35-mm glass-based dishes were transiently transfected with plasmid DNA 
on the preceding day. (i) Time-lapse monitoring was performed using a Fluoview FV500 laser scanning 
microscope with a 40x 1.00 oil objective. Time-lapse images were obtained at low power laser (0.3-3.0% laser) 
using the 488 nm line of an argon laser. (ii) FRAP experiments were performed as described (67). If necessary, 
COS-1 cells were treated with 200 g/ml cycloheximide for 2 hours to inhibit protein synthesis before live cell 
images were obtained. The areas enclosed by yellow circles were photobleached at full laser power (100% laser) 
using the 488 nm line of an argon laser, and cells were imaged at low laser power (0.3-3.0% laser). All images 
were obtained as 2 m thick of one planar (xy) section. Cells were maintained at 37°C in a 
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temperature-controlled box. Mean fluorescence intensities were quantified using Fluoview Tiempo time course 
version 4.2 software. Composite figures were prepared using Photoshop 5.0 and Illustrator 9.0 software (Adobe). 
 
Western blotting 
Western blotting was performed as described previously (22, 50, 55, 67). In brief, lysates were prepared in Triton 
X-100 lysis buffer (50 mM Hepes, pH 7.4, 10% glycerol, 1% Triton X-100, 4 mM EDTA, 100 mM NaF, and 1 
mM Na3VO4) containing 50 g/ml aprotinin, 100 g/ml leupeptin, 25 M pepstatin A and 2 mM PMSF. Equal 
amounts of lysates were subjected to 10% SDS-polyacrylamide gel electrophoresis and electrotransferred onto 
polyvinylidene membranes. After blocking with TBS-T (25 mM Tris-HCl, pH 7.2, 0.9% NaCl, and 0.1% Tween 
20) containing 5% BSA under gentle shaking for 1 hour, the membrane was incubated with 3% BSA containing 
a primary and a secondary antibody for 1 hour each. Immunodetection was performed by enhanced 
chemiluminascence (Amersham) using an Image Analyzer LAS-1000plus (Fujifilm, Tokyo, Japan). Composite 
figures were prepared using Photoshop 5.0 and Illustrator 9.0 software (Adobe). 
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